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ABSTRACT 
 
Prostaglandin F2α (PGF2α) has been shown to have detrimental effects on 
embryonic development, quality and hatching ability of embryos and pregnancy rates in 
cows. However, information about PGF2α receptor (FPr) mRNA and protein in the pre-
attachment bovine embryo is absent in the literature. The first experiment was design to 
identify the period of time during in vitro embryo development that is most susceptible to 
PGF2α and to determine FPr mRNA and protein in bovine embryos. Prostaglandin F2α 
decreased development of embryos to compact morula, but had no effect on development 
to blastocyst. In addition, FPr mRNA and protein was confirmed by real time PCR and 
Western Blot analysis, respectively, suggesting that PGF2α is having a direct negative 
effect on in vitro development of bovine embryos by activating its receptor. 
Discovery of FPr in bovine embryos allowed for development of new therapeutic 
strategies aimed at improving reproduction in bovines. Therefore, in a second 
experiment, the effects of a selective FPr antagonist, AL-8810, on in vitro development 
of bovine embryos was evaluated. The antagonist did not have toxic effects on 
development of embryos. Subsequently, efficacy of AL-8810 to prevent PGF2α effects on 
pre-compacted embryos was investigated. Results showed that addition of AL-8810 to 
the culture medium inhibited PGF2α effects on development to morula stage.  
In a third experiment, embryonic development and gene expression of Na+/K+ 
ATPase α1 and zonula occludens-1 (ZO-1), two important genes participating in 
blastocyst formation and hatching, was examined after culture of in vivo-derived 
frozen/thawed bovine embryos with AL-8810, PGF, AL-8810+PGF, or Control. 
Thereafter, pregnancy rates of embryos recovered with medium containing AL-8810 was 
 v
evaluated. Results indicated that AL-8810 inhibited negative effects of PGF2α on 
development of embryos; however, no differences in gene expression were observed. 
Furthermore, recovery of embryos with medium containing AL-8810 improved 
pregnancy rates following transfer to recipient cows. In conclusion, inhibition of PGF2α 
binding to its receptors on in vitro- and in vivo-derived bovine embryos increases 
embryonic development and pregnancy rates after transfer to recipient animals; 
respectively. These findings will likely increase efficiency of in vitro production of 
embryos and embryo transfer programs in cattle. 
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CHAPTER 1 
INTRODUCTION 
Reproductive losses associated with the beef industry in the United States are 
estimated to cost $500 million dollars annually (Bellows et al., 2002). Early embryonic 
death accounts for 75 to 80% of all reproductive losses (Sreenan and Diskin, 1983). The 
majority of these losses occur when the embryo enters the uterus (5-8 days after mating 
or insemination) and the morula stage embryo is developing into blastocyst (Ayalon, 
1978; Maurer and Chenault, 1983; Sreenan and Diskin, 1983; Wiebold, 1988; Dunne et 
al., 2000). 
Prostaglandins are potent chemical mediators derived from arachidonic acid 
metabolism that participate in several physiological processes. Studies have linked 
prostaglandins with several pathological conditions such as cancer, inflammation, and   
neurodegenerative diseases (Ishihara et al., 2004; Hoozemans and O'Banion, 2005). In 
cattle, elevated prostaglandin F2α (PGF2α) concentrations in the uterine lumen has also 
been shown to lower reproductive efficiency by decreasing embryonic survival and 
development (Harper and Skarnes, 1972; Maurer and Beier, 1976; Breuel et al., 1993; 
Schrick et al., 1993; Buford et al., 1996; Hockett et al., 2004; Scenna et al., 2004), 
decreasing the ability of bovine embryos to escape from the zona pellucida (hatching; 
(Scenna et al., 2004)), and by decreasing pregnancy rates (Lemaster et al., 1999; Sales et 
al., 2004; Scenna et al., 2005). Further implications for PGF2α as an embryotoxic agent 
was observed when administration of several prostaglandin synthesis inhibitors increased 
pregnancy rates after embryo transfer in cows (Elli et al., 2001; McNaughtan et al., 2002; 
Pugh et al., 2004; Purcell et al., 2004; Scenna et al., 2005).  
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To date, the mechanisms through which PGF2α reduces embryonic survival and 
development in the cow are still unclear. In addition, the presence of prostaglandin PGF2α 
receptors (FPr) in pre-attachment bovine embryos has not been documented in the 
literature. Therefore, the objectives of this dissertation were 1) to identify the period of 
time during in vitro embryo development where the embryo is most susceptible to 
detrimental effects of PGF2α, 2) to determine the presence of FPr mRNA and protein in 
bovine embryos; 3) to inhibit detrimental effects of PGF2α on embryo development by  
addition of a selective FPr antagonist, AL-8810, to the culture medium of embryos 
treated with PGF2α; and lastly 4) to improve pregnancy rates after bovine embryo transfer 
by transferring embryos treated with AL-8810. 
In conclusion, PGF2α is a primary cause of embryonic loss in cattle. Therefore, 
understanding the mechanism/s by which PGF2α causes its effects on the embryo will 
allow the development of new therapeutic strategies to improve embryo quality, 
development and survival. These improvements will result in better production efficiency 
(due to an increase in pregnancy rates and subsequent calving rates) and higher monetary 
earnings to the cattle industry (due to an increase in cattle sales).  
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CHAPTER 2 
LITERATURE REVIEW 
 
1. Early embryonic development 
Establishment of a viable pregnancy in cattle depends on many complex 
processes. Functional gametes must be produced by both sexes, the female must show 
estrus, mating must occurr within the functional lifespan of the gametes, and proper 
uterine environment and corpus luteum functionality must ensure embryonic and fetal 
development.   
In the cow, a population of primordial follicles containing an oocyte arrested at 
prophase of the first meiotic division (immature oocyte) is established during fetal life 
(van Wezel and Rodgers, 1996). During each estrous cycle, two or three follicular waves 
occur in which a group of follicles are recruited to initiate growth (Savio et al., 1988; 
Ginther et al., 1989; Fortune, 1993). During each follicular wave, only one of these 
follicles becomes dominant and continues to grow, while subordinate follicles regress 
(Knopf et al., 1989). Upon luteolysis (destruction of the corpus luteum by PGF2α), the 
dominant follicle increases in size and produces estradiol 17β to “trigger” a preovulatory 
peak of luteinizing hormone (LH) and estrous behavior. Luteinizing hormone causes the 
oocyte in the dominant follicle to resume meiosis (progresses to metaphase of the second 
meiotic division) and ovulation to take place (Espey, 1994).  
After expulsion of the matured oocyte from the ovulatory follicle, the oocyte is 
collected by the oviduct. The oviduct is comprised of four distinct regions: infundibulum, 
ampulla, ampullary-isthmic junction, and isthmus (Ellington, 1991). The mature oocyte is 
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captured by the infundibulum and transported to the ampullary-isthmus junction where 
capacitated sperm bind to the zona pellucida surrounding the oocyte, undergoes acrosome 
reaction and penetrates the oocyte’s plasma membrane (Saling, 1991). After fertilization 
and organization of the male and female pronuclei, the zygote becomes an embryo that 
undergoes a series of synchronized cell divisions (also called cleavage divisions; Figure 
1).  
The first cleavage division generates a two-cell embryo, in which cells are called 
blastomeres. As the early embryo is transported through the isthmus region of the 
oviduct, each blastomere undergoes subsequent divisions yielding 4-, 8-, 16- and 32-cell 
embryos (Figure 1). The embryo enters the uterine horn on day 5-6 after estrus; at which 
time, blastomeres flatten against each other forming a “solid ball” of cells called a morula 
(Figure 1). The morula stage embryo begins to form a fluid filled cavity (the blastocoele) 
and the embryo is classified as a blastocyst (Watson et al., 1992). Throughout all these 
developmental stages, blastomeres become smaller with no net increase in size of the 
embryo. Further accumulation of fluid within the blastocoele allows the embryo to 
expand (expanded blastocyst) and finally hatch (escape) from the zona pellucida (hatched 
blastocyst) on approximately day 9 after estrus (Van Soom et al., 1997). 
 In cattle, hatching is a critical step for a successful pregnancy because it allows 
filamentous development of the embryo and posterior attachment of the embryo to the 
uterine endometrium. Similarly, low implantation rates of in vitro-fertilized human 
embryos are largely due to impaired development and hatching of blastocyst (Magli et 
al., 1998).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cleavage Divisions
Compaction
E-cadherin
Gap Junctions
Tight Junctions 
Polarization
EGA
Oocyte 2-cell 8- to 16- cell E. Morula C. Morula Blastocyst4-cell
E-cadherin activation
Day 1 Day 2 Day 3 and 4 Day 5 Day 6 Day 7
 
 
 
 
 
 
 
 
Figure 1. Important events during development of bovine embryos. After fertilization, the 
zygote suffers a series of well orchestrated cell divisions (cleavage divisions) leading to 
the formation of first a compact morula (C. Morula) and later a blastocyst stage embryo. 
Presence of maternally inherited and embryonic E-cadherin allows compaction to occur. 
Following compaction, outer cells of the compact morula develop tight junctions, 
whereas inner cells develop gap junctions. Outer cells polarize and differentiate in 
trophectoderm cells, whereas inner cells remain apolar and differentiate into the inner cell 
mass. EGA= embryonic genome activation. Approximate days after insemination are 
depicted for every stage of development. 
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2. Embryonic genome activation and gene expression in bovine embryos 
 
After fertilization of the oocyte, several important events occur during 
development of an early bovine embryo. These include the first cleavage division, the 
activation of the embryonic genome, compaction, formation of the blastocoele and cell 
differentiation. Embryonic genome activation is considered the most important of these 
events due to the fact that it leads the way to further development. Without genome 
activation, an early bovine embryo stops development at the 8 to 16-cell stage embryo, a 
phenomenon known as “developmental block” (Meirelles et al., 2004). Maternal mRNAs 
and proteins, accumulated in the oocyte’s cytoplasm during its growing phase within the 
follicle, are able to support early embryonic divisions (Briggs et al., 1951; Fair et al., 
1997). However, further development is achieved only by activation of the embryonic 
genome, which allows the embryo to synthesize its own mRNA and proteins. Initiation of 
this process differs between species: 1-cell stage in the mouse (Aoki et al., 1997), 4-cell 
stage in humans (Braude et al., 1988), and 8- to 16-cell stage in cattle (Camous et al., 
1986), sheep (Crosby et al., 1988), and rabbits (Manes, 1973).  
In the mouse, the majority of maternal proteins and mRNA are degraded during 
transition from maternal to embryonic genome activation (Latham et al., 1991). In fact, 
adenylation and degradation of maternal mRNA are initiated during meiotic maturation 
and results in a net loss of 30% of polyadenylated mRNA pools between fully grown 
oocytes and ovulated oocytes (Bachvarova et al., 1985). Active turnover of mRNA 
continues and the majority of poly-A tail mRNA is degraded by the 2-cell stage embryo 
(Piko and Clegg, 1982). At the same time, a major activation of the embryonic genome 
occurs (Aoki et al., 1997). About 50% of these newly synthesized transcripts are absent 
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from the maternal population of mRNA (Taylor and Piko, 1987). During maternal to 
embryonic genome activation in the mouse, ribosomal RNA and ribosome numbers 
decrease only 25% (Piko and Clegg, 1982). Moreover, small nuclear RNAs (snRNAs) 
from maternal origin, responsible for processing new transcripts into functional mRNA, 
are not degraded during the transition from maternal to embryonic genome activation 
(Dean et al., 1989). This suggests that in the mouse, mRNA synthesized during 
embryonic genome activation appears to be processed by snRNAs of maternal origin.  
In the cow, a gradual decrease in protein concentration is observed from the 
oocyte through the 8-cell stage (Frei et al., 1989). Following embryonic genome 
activation at the 8-cell stage embryo, a marked increase in total mRNA and proteins 
occurs (Camous et al., 1986; Frei et al., 1989). Memili and coworkers (1998) suggested a 
minor genome activation between the 1- and the late 4-cell stages and a major genome 
activation at the 8-cell stage in bovine embryos. There is a positive correlation between 
genome activation and the duration of the cell cycle in bovine embryos (Barnes and 
Eyestone, 1990). The total length for the first cell cycle is 28 h, 24 h for the second cell 
cycle (without G1 or G2), 14 h for the third cell cycle (without G1), and 24-28 h for the 
fourth cell cycle (with both G1 and G2, coinciding with the activation of the embryonic 
genome). During embryonic genome activation, several important genes for cell 
proliferation, compaction and blastocyst formation are activated. Some of those genes 
include expression of growth factors and their receptors (Rappolee et al., 1990), cell 
adhesion molecules (Kidder, 1987) and Na+/K+ ATPase enzyme (Watson and Kidder, 
1988).  
 
 8
3. Protein content of bovine oocytes and embryos 
A major feature of mammalian embryogenesis is a marked change in the pattern 
of protein synthesis as the embryo proceeds through early cleavage divisions. During this 
period of time, populations of both maternal RNA and proteins that had been stored in the 
oocyte during oogenesis are sufficient to support early embryonic development to the 2 
cell stage in mouse (Golbus et al., 1973), 4-8 cell stage in humans (Braude et al., 1988), 
8-cell stage rabbits (Manes and Daniel, 1969; Schultz et al., 1973) and 8 to16-cell stage 
in sheep and bovine embryos (Crosby et al., 1988; Frei et al., 1989). Due to degradation 
of these stored molecules, subsequent development is dependent upon transcriptional 
activation of the embryonic genome.   
Protein synthesis of bovine oocytes and early stage embryos (up to 16-cell stage) 
was first analyzed by Frei et al. (1989) after culturing in vivo-derived embryos in medium 
containing radiolabelled methionine. In this study, marked changes in the pattern of 
synthesis were observed at the 8-16-cell stage of development. Quantitatively, a gradual 
decrease in rate of protein synthesis occurred between the zygote and the 8-cell stage and 
then increased progressively to the blastocyst stage. Grealy and coworkers (1996) were 
the first to actually report the amount of protein in bovine oocytes and in vivo-derived 
embryos. Authors concluded that protein content of oocytes and 2-cell stage embryos was 
very similar (0.126 and 0.132 ug per oocyte and embryo, respectively), higher in morula 
and blastocyst stage embryos (0.183 and 0.185 μg per embryo, respectively), and even 
higher for the expanded blastocyst stage embryo (0.367 μg). Also, a 160- and more than 
2000-fold increase in protein content of hatched blastocysts recovered on day 13 and 16, 
respectively, was observed when compared to protein content of expanded blastocysts on 
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day 8. These findings are in agreement with those reported by Frei et al. (Frei et al., 
1989) and suggest that the increase in protein content from the 2-cell stage embryo 
onwards is related to the activation of the embryonic genome at the stage of 8- to 16-cell 
(Camous et al., 1986; Memili et al., 1998), an event followed by a sharp increase in 
protein synthesis in the embryo. The protein content of bovine oocytes and in vitro-
derived embryos was recently reported by Thompson and collaborators (1998). Despite 
using different techniques to determine protein content in the embryo (BCA vs. Lowry 
methods), the amount of protein in ova and pre-compacted stage embryos reported by 
these two studies were similar. On the other hand, protein content between in vivo-
derived (Grealy et al., 1996) and in vitro-derived (Thompson et al., 1998) expanded 
blastocysts differed between these two studies (367 ± 28 vs. 152 ± 10 ng per embryo, 
respectively). However, it is worth noting that Thompson and coworkers utilized in vitro-
derived zona pellucida-free embryos to determine protein content, and when using zona 
pellucida-enclosed expanded blastocyst, the total amount of protein was estimated to be 
337 ± 58 ng per embryo. Therefore, the authors estimated that the protein content of the 
zona pellucida from in vitro-derived embryos is approximately 200 ng.   
In summary, data demonstrate that protein content decreases prior to compaction 
and increases after compaction and during the formation of the blastocyst (Frei et al., 
1989; Thompson et al., 1998). This pattern suggests that during pre-compaction 
development, levels of protein degradation are higher than protein synthesis and that net 
growth is observed only after the activation of embryonic genome.  
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4. Compaction and blastocyst formation  
Compaction represents a key critical event for continued embryonic development. 
It allows polarization and differentiation of blastomeres into two different cell 
populations (by induction of cell adhesion molecules between blastomeres that enhance 
cell communication and adherence) and facilitates fluid accumulation within the embryo 
that directly contributes to blastocyst formation and subsequent hatching from the zona 
pellucida (Watson, 1992). Compaction appears to occur in all mammalian embryos but 
timing differences exist between species: mouse at 8-cell stage (Ducibella and Anderson, 
1975), humans at 16-cell stage (Edwards et al., 1981), and bovine (Van Soom et al., 
1997) and rabbit (Koyama et al., 1994) at 32-cell stage. 
During compaction, blastomeres adhere to and flatten against each other and 
boundaries between cells cannot be recognized (Van Soom et al., 1997). Development of 
the Ca++-dependent cell adhesion molecule E-cadherin allows the establishment of gap 
and tight junctions leading to cellular and morphogenetic differentiation of blastomeres 
(Braga, 2002). Outer blastomeres polarize and form the trophectoderm (TE), while inner 
blastomeres remain apolar and generate the inner cell mass (ICM;(Koyama et al., 1994). 
The inner cell mass forms the embryo proper and some extra-embryonic membranes; 
whereas, trophectoderm cells will combine with ICM-derived extra-embryonic 
membranes to form the fetal placenta (Schlafer et al., 2000). The increase in 
interblastomeric contacts during compaction is mediated mainly by the action of E-
cadherin, a Ca++-dependent cell adhesion molecule (Pratt et al., 1982; Riethmacher et al., 
1995), but also by action of microfilaments and microtubules (Pratt et al., 1981), high 
intracellular levels of Ca++ (Pey et al., 1998), and activation and phosphorylation of 
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proteins by protein kinase C (Winkel et al., 1990). In fact, compaction can be inhibited or 
disrupted by addition of cytochalasin D (antimycotic drug that depolymerizes 
microfilaments), colcemid (a derivate of colchicines, a plant toxin that inhibits 
microtubule polymerization) or by culturing embryos in Ca++-free medium (Pratt et al., 
1981; Pratt et al., 1982; Reima, 1990). In addition, activation of PKC with phorbol ester 
or treatment with diacylglycerides caused 4-cell mouse embryos to compact ahead of 
normal timing, while PKC inhibitors prevented compaction (Winkel et al., 1990). 
During compaction, the free or apical membrane surfaces of the outer cells 
develop a microvillus cap with several Na+/dependent transport systems (Miller and 
Schultz, 1985; Fleming and Johnson, 1988). These transport systems play a central role in 
establishment of an ion concentration gradient across the epithelium that facilitates 
osmotic accumulation of water into the blastocoelic space to form the nascent blastocoele 
(Biggers et al., 1988). Basolateral surfaces of TE remain free of microvilli, but become 
distinguished from apical surfaces by localization of tight junctions (Fleming et al., 
1989), gap junctions (Kidder, 1987), adherent junctions (Vestweber et al., 1987), and 
acquisition of an active Na+/K+ ATPase pump (Watson et al., 1999).  
In summary, during compaction, increase of interblastomeric contacts mediated 
by several adhesion molecules (mainly E-cadherin) induces cell polarization and 
differentiation of blastomeres into two cell populations, the TE epithelium and the ICM. 
Moreover, the trophectoderm develops the capacity to initiate and regulate blastocoele 
formation by the action of Na+/K+ ATPase enzyme (especially in the basolateral surface 
TE epithelium) and the presence of tight junction at the apical part of the TE epithelium 
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that prevents uncontrolled leakage of this fluid from the blastocoele cavity (Watson et al., 
1992).  
 
5. Role of E-cadherin during embryonic development 
E-cadherin has three major domains or regions: an extracellular domain 
responsible for specific recognition of the same cadherin present in neighboring cells, a 
transmembrane domain that spans the cell membrane, and a cytoplasmic domain that 
extends into the cell and associates with cytoplasmic proteins called catenins, which in 
turn bind cadherins to actin filaments in the cytoskeleton (Ivanov et al., 2001). In the 
mouse, E-cadherin is expressed in the oocyte and during the early period of embryonic 
genome activation (at 2-cell stage; (Vestweber et al., 1987). E-cadherin-mediated 
adhesion between blastomeres initiates compaction and plays a critical role in 
differentiation of the trophectoderm and morphogenesis of the mouse blastocyst (Fleming 
and Hay, 1991). E-cadherin is uniformly distributed on the surface of all mouse 
blastomeres during early cleavage but redistributes to cell-cell contact sites upon 
activation at the 8-cell stage (when compaction begins) suggesting post-translational 
regulations. In fact, E-cadherin becomes phosphorylated for the first time at compaction 
(Sefton et al., 1992). In addition, homozygous null mutant mouse embryos for the E-
cadherin gene initially compact (an event attributed to the presence of maternal or 
oogenetic E-cadherin proteins) but then proceed to decompact, with cells becoming 
apolar due to interference in the formation of apical junctional complexes (Laure et al., 
1994; Riethmacher et al., 1995). Moreover, these embryos fail to develop a normal 
blastocoele cavity and do not hatch from the zona pellucida (Riethmacher et al., 1995). 
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Fibroblast cells lost cell-cell contacts (Erez et al., 2004) and mouse embryos 
decompacted (Reima, 1990) when exposed to antibodies directed against Ca++-dependent 
molecules, further suggesting involvement of E-cadherin during compaction. 
In cattle, E-cadherin is evenly distributed around cell margins of 1-cell zygotes 
and cleavage stage embryos and becomes restricted to basolateral membranes of outer 
cells at morula stage, while maintaining apolar distributions in the ICM (Barcroft et al., 
1998). This suggests an involvement of E-cadherin in the formation of junctional apical 
complexes during the bovine compaction process. In a recent study, targeted disruption of 
the E-cadherin gene in bovine preimplantation embryos by RNA interference technology 
resulted in less embryos reaching compact morula or blastocyst stage (Nganvongpanit et 
al., 2006). These findings indicate a critical role of E-cadherin not only during 
compaction, but furthering embryonic development. 
 
6. Role of tight junctions during embryonic development 
Tight junctions are a “belt-like”, multiprotein complex around each cell and 
represent a site of close intercellular adhesion including partial membrane fusion. Tight 
junctions form a barrier against paracellular diffusion, generate a trans-epithelial 
resistance, and allow accumulation of fluid during blastocoele formation (Biggers et al., 
1988). Tight junctions comprise several proteins (both transmembrane and cytoplasmic) 
with the most important being zonula occludens 1 (ZO-1α+ and ZO-1α-; (Willott et al., 
1992)) and cingulin (Citi, 1993). Although tight junction formation does not begin until 
compaction of the 8-cell stage mouse embryo (a process dependent upon E-cadherin 
activation), immunoblotting of unfertilized oocytes and preimplantation mouse embryos 
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showed high levels of cingulin in oocytes and early cleavage stages up to the 16-cell 
(Javed et al., 1993), indicating a maternal inheritance of these transcripts and protein.  
During compaction in the mouse, outer cells gradually envelope inner cells 
causing ZO-1 in the inner cells to disappear. Thus, symmetrical cell contact appears to 
initiate ZO-1 down regulation in the ICM lineage (Fleming and Hay, 1991). In cattle, 
ZO-1 is undetectable until the morula stage when it first appears as punctuate points 
between outer cells. In blastocysts, ZO-1 is localized as a continuous ring at apical points 
of trophectoderm or outer cell contacts, whereas it remains undetectable in the ICM 
(Barcroft et al., 1998). Miller and coworkers (2003) reported that the amount of tight 
junction mRNA in in vitro-derived bovine embryos is dependent on the ability to undergo 
a well-orchestrated compaction process. In this study, when blastocyst developed after a 
short compaction period, expression of total tight junction mRNA was lower than in 
blastocysts derived from a longer compaction process. Moreover, a dramatic increase in 
ZO-1 was observed during transition from morula to blastocyst stage both in in vivo and 
in vitro-derived embryos, suggesting a stage-dependent rather than a time-dependent up-
regulation of embryonic transcription just prior to blastocyst formation. 
 
7. Role of the Na+/K+ ATPase pump during embryonic development 
The Na+/K+ ATPase is composed of two obligatory subunits, a catalytic, 
nonglycosylated α-subunit and a glycosylated β-subunit (Jorgensen, 1982). The α-subunit 
is responsible for the physiological role of the enzyme (Jorgensen, 1986), while the β-
subunit may facilitate processing and insertion of the α-subunit into the plasma 
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membrane (Geering, 1991). These subunits are encoded by multi-gene families as four α-
subunits (α1, α2, α3, α4) and two β-subunit (β1, β2) have been cloned (Kent et al., 1987).  
In the mouse, this enzyme is first detected at the late morula stage within the 
cytoplasm of each blastomere; but when cavitation begins, its distribution changes 
dramatically to a ring encircling the blastocoele, and restricted to the basolateral cell 
margins (Watson and Kidder, 1988). Moreover, northern hybridization experiments have 
detected transcripts for only the α1-subunits in all stages of mouse preimplantation 
development (Watson et al., 1990). In contrast, in vitro-produced bovine embryos 
expressed multiple α- and β-subunits of this enzyme throughout early development (Betts 
et al., 1998). Furthermore, the bovine Na+/K+ ATPase enzyme is more sensitive to effects 
of ouabain (an inhibitor of Na+/K+ ATPase) than the one present in murine embryos 
(Betts et al., 1998). In addition, Na+/K+ ATPase transcripts were detected in the ICM 
cells and trophectoderm cells of bovine blastocysts (Wrenzycki et al., 2003). Wrenzycki 
et al. (2003) investigated gene expression directing bovine blastocyst formation in TE 
and ICM cells and reported that Na+/K+ ATPase, E-cadherin, ZO-1 and glucose 
transporter-3 transcripts were higher in TE cells when compared to ICM cells. In 
contrast, desmocollin II and glucose transporter-1 and -4 were more abundant within 
ICM cells. These results demonstrate a specific gene expression pattern between these 
two cell lines in the early embryo regulating preimplantation development.  
 
8. Role of gap junctions during embryonic development  
Gap junctions are channels present in opposing plasma membranes of neighboring 
cells (Kidder and Wintergaher, 2001). The cell membranes come close together, but are 
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separated by 2-4 nanometers. These junctions are composed of at least 13 different 
proteins called connexins (Bruzzone and Goodenough, 1996; De Sousa et al., 1997); 
however, several studies identified connexin 43 as the most important gap junctional 
protein expressed in mouse (De Sousa et al., 1993; Valdimarsson and Kidder, 1995), 
bovine (Wrenzycki et al., 1996; Wrenzycki et al., 1999), and rat (Reuss et al., 2002) 
preimplantation embryos.  
Intercellular communication through gap junctions is believed to be essential for 
cellular growth, differentiation and development (Warner, 1987; Zhang and 
Thorgeirsson, 1994). At the plasma membrane, six copies of the same connexin form a 
hexagonal ring-shaped channel called connexon. Connexons in adjacent cell membranes 
align together to form a hydrophilic channel that allows direct passage of molecules up to 
1 kDa such as ions, cyclic AMP, Ca++, and inositol trisphosphate (IP3) between cells, and 
thereby coordinate metabolic and electrical activities.  
In mouse, assembly of functional gap junctions is first observed during 
compaction in 8-cell stage embryos (Lo and Gilula, 1979; McLachlin et al., 1983) and 
represents a critical step for maintenance of compaction and subsequent blastocyst 
formation (Lee et al., 1987; Bevilacqua et al., 1989). Injection of gap junction antisense 
RNA to 2- and 4-cell mouse embryos reduced the percentage of compacted embryos to 
less than 20%, while 90% of uninjected embryos compacted (Bevilacqua et al., 1989). 
Also, when the same antisense was injected to 8-cell mouse embryos, only 5% of the 
embryos developed to blastocyst stage, while blastulation occurred in 90% of control 
embryos. Similarly, injection of gap junction antibodies inhibited dye transfer and 
dramatically reduced electrical coupling of 8-cell mouse embryos (Lee et al., 1987). 
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Moreover, preimplantation mouse embryos deficient in connexin 43 retained the capacity 
for cell-to-cell transfer of fluorescent dye (dye coupling), but at a severely reduced dye 
coupling (De Sousa et al., 1997).  
Literature on intercellular communication through gap junctions in early bovine 
embryos is limited. Utilizing polymerase chain reaction (PCR), Wrenzycki and 
colleagues (1996) reported that transcripts for connexin 43 were present in immature 
oocytes and in all developmental stages of in vitro-produced embryos up to the morula 
stage. In contrast, only in vivo-derived morula and blastocyst stage embryos expressed 
connexin 43.  These findings agree with reports from Boni et al. (1999) that demonstrated 
diffusion of dye between ICM cells of in vivo-derived morula stage embryos and ICM 
cells of in vitro-produced blastocyst stage embryos. Moreover, junctional conductance 
was higher in in vivo embryos than in in vitro embryos, with isolated ICM cells from both 
groups of embryos showing greater conductance compared to intact blastocyst. Higher 
junctional conductance was also correlated with higher density of gap junctions in in 
vivo-derived embryos than their in vitro counterparts. Prather and First (1993) also 
reported that in vivo-derived morula and blastocyst stage embryos showed dye transfer 
indicating the existence of gap junctions. However, in vitro-produced morula and 
blastocyst stage embryos did not show spreading of dye. Differences in dye transfer 
between Boni et al. (1999) and Prather and First (1993) studies may be explained by the 
fact that in the later, injection of dye to in vitro embryos was only performed on TE cells, 
and as Boni et al. (1999) demonstrated, no transfer of dye was observed in TE cells 
derived from in vitro embryos. 
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9. The zona pellucida, structure and functions 
The zona pellucida (ZP) is an extracellular matrix surrounding growing oocytes, 
ovulated oocytes, and early stage embryos (Baker, 1972). The ZP exerts several 
important functions such as binding to spermatozoa in a specie-specific manner, 
induction of sperm acrosome reaction, blocking polyspermy, preventing the dispersion of 
blastomeres during preimplantation development, facilitating the passage of the embryo 
through the oviduct, and protecting the embryo during early stages of development 
(Wassarman, 1990, 1990; Epifano and Dean, 1994). 
The majority of data generated on the structure and function of the ZP were 
obtained from studies performed in mouse and has been used as a model for other 
species. The mouse ZP is approximately 7 μm thick, and consists of three glycoproteins 
called mouse (m) ZP1, mZP2, and mZP3, with molecular weight of approximately 200, 
120, and 83 kD, respectively (Bleil and Wassarman, 1980). All these ZP glycoproteins 
are exclusively secreted by the growing oocyte until time of ovulation (Bleil and 
Wassarman, 1980). These glycoproteins are organized in a specific manner within the 
extracellular matrix. Dimers composed of mZP2 and mZP3 polymerize into long 
filaments that constitute the ZP. The mZP1, a dimer of identical polypeptides, serves as 
the cross-linker between filaments. Ovaries from homozygous null female mice for mZP3 
(mZP3-/-) contained growing oocytes without ZP, while oocytes from heterozygous null 
females (mZP3+/-) had a ZP half the thickness of those from wild-type female mice (Liu 
et al., 1996; Rankin et al., 1996). Homozygote female mice for mZP3 exhibited normal 
reproductive behavior, but failed to become pregnant after mating with fertile wild type 
male mice. 
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In addition, mZP3-/- female mice carrying a human ZP3 (hZP3) transgene 
possessed a thick ZP that consisted of mZP1, mZP2 and hZP3 (Rankin et al., 1998). In 
addition to the structural role of mZP3 during ZP formation, the mZP3 serves also as a 
receptor for sperm (Bleil and Wassarman, 1980). Only purified mZP3 binds specifically 
to heads of acrosome-intact sperm and prevents sperm from binding to ovulated oocytes 
in vitro (Bleil and Wassarman, 1980). On the other hand, mZP3 from fertilized oocytes or 
early embryos did not prevent binding of sperm to the ZP of ovulated oocytes in vitro 
(Bleil and Wassarman, 1980), which suggests that protein changes in ZP3 after 
fertilization inhibit further binding of sperm to the ZP. Acrosome intact sperm recognize 
and bind to specific O-linked oligosaccharides located on serine residues (serine 332 and 
334) near the carboxy terminus of mZP3 polypeptide (Kinloch et al., 1995). Moreover, 
certain oligosaccharides inhibited binding of mouse sperm to oocytes in vitro (Litscher et 
al., 1995) indicating that binding of sperm to oocytes is a carbohydrate-mediated event. 
The mZP3 also triggers the acrosome reaction in sperm (Bleil and Wassarman, 1983), 
which allows sperm to penetrate the zona pellucida and fuse with the oocyte’s plasma 
membrane. During acrosome reaction, the sperm remains bound to the ZP by binding to 
mZP2 (Bleil et al., 1988). 
Zona pellucida glycoproteins are found in ZP of oocytes from virtually all 
mammalian species, from mice to humans (Wassarman et al., 1999; Wassarman, 1999) 
with a remarkable similarity in amino acids homology between species. In bovine, the ZP 
is composed of only a few highly modified glycoproteins; bovine (b) ZP1, bZP2, bZP3α, 
bZP3β, and bZP4 (Topper et al., 1997). The sperm receptor activity is attributed to ZP3α, 
while ZP2 serves as a secondary receptor for acrosome-reacted sperm. After sperm-egg 
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fusion, enzymes released by the cortical granules during the cortical reaction convert ZP2 
and ZP3 to ZP2f and ZP3f, respectively. These modifications inhibit further fusion of 
sperm with the oocyte’s plasma membrane, a phenomenon called block of polyspermy 
(Kopf, 1990).  In addition to ZP glycoproteins, passage of an early embryo through the 
oviduct allows the incorporation of several other proteins secreted by the oviductal 
epithelium (Buhi et al., 2000; Buhi, 2002). 
Contrary to the mouse, where the growing oocyte is the only source of zona 
glycoproteins (Flechon et al., 1984), investigations in other species such as human 
(Grootenhuis et al., 1996), monkey (Grootenhuis et al., 1996), rabbit (Grootenhuis et al., 
1996), dog (Tresoriero, 1981), pig (Sinowatz et al., 1995) and cow (Kolle et al., 1998) 
have shown that both the oocyte and the follicle cells (corona radiate cells) contribute to 
the synthesis of ZP glycoproteins. These finding have been supported by in vitro cell 
culture of granulosa cells that were able to secrete ZP glycoproteins (Skinner et al., 
1984).  During follicular development in the bovine ovary, the ZP3β protein and its 
mRNA are primarily localized in the oocytes of primordial and primary follicles 
(Sinowatz et al., 1995; Kolle et al., 1998). In secondary follicles, both the oocyte and 
granulosa cells express ZP3β protein and transcripts (Sinowatz et al., 1995; Kolle et al., 
1998). In tertiary and pre-ovulatory follicles, both protein and transcripts are found in the 
cytoplasm of granulosa cells (Sinowatz et al., 1995; Kolle et al., 1998).  In addition, 
investigations in fetal bovine ovaries have shown that ZP proteins are synthesized by the 
oocyte and granulosa cells during prenatal development (Totzauer et al., 1998). 
When visualized by scanning electron microscopy (SEM), the mammalian ZP is 
found to be composed of a network dispersed with numerous pores (Dudkiewicz and 
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Williams, 1977) and with morphologically dissimilar internal and external surfaces. The 
external surface displays a fenestrated lattice-like appearance and the internal surface 
shows a regular rough appearance (Phillips and Shalgi, 1980). When pores are compared 
among species, the largest pores are observed in the ZP of the rabbit and the cat, and the 
smallest in the cow. The pores are largest at the outer surface of the ZP but decrease in 
size centripetally (Dudkiewicz and Williams, 1977). Vanroose and coworkers (2000) 
studied the outer ZP surface of bovine oocytes, zygotes, 8-cell stage and morula stage 
embryos. In this study, the outer ZP surface of bovine oocytes and morulae showed a 
rough and spongy appearance with numerous pores. On the other hand, the outer ZP 
surface of zygotes was found to have a smooth, melted appearance with only a few pores 
and 8-cell stage embryos presented both surface patterns. The mean number of pores was 
1511 in oocytes, 1187 in zygotes, 1658 in 8-cell stage embryos, and 3259 in morulae, 
with mean diameters of 182, 223, 203, and 155 nm, respectively. In the same study, the 
ability of fluorescent microspheres of 40-50 nm and 180-200 nm to traverse the ZP was 
evaluated. Authors concluded that for all stages evaluated, the smallest beads were 
detected half way through the thickness of the ZP, whereas the biggest beads remained 
only at the outer surface of the ZP.  
 
10. Hatching process  
In cattle, accumulation of fluid (between days 8 and 10 after fertilization) within 
the blastocoele cavity in the blastocyst distends the zona pellucida (ZP), which becomes 
gradually thinner until it ruptures allowing escape of the blastocyst by protrusion through 
the opening in the ZP (Flechon and Renard, 1978; Massip and Mulnard, 1980). 
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Accumulation of fluid within the blastocoele cavity is achieved by a sodium 
concentration gradient created in the blastocoele cavity by the presence and function of 
the Na+/K+-ATPase pump (Biggers et al., 1988) at the basolateral surface of the 
trophectoderm epithelium. Additionally, the presence of a junctional apical complex 
(formed by tight junction at the apical part of the TE epithelium) prevents uncontrolled 
leakage of this fluid from the blastocoele cavity (Watson et al., 1992; Bavister, 1995).   
In hamster and mouse embryos, hatching results from degradation of the ZP by 
enzymes originated from the embryo and/or the uterus (Gordon and Dapunt, 1993; 
Gonzales and Bavister, 1995). In fact, hatching of in vitro-produced mouse blastocyst has 
been related to a trypsin-like proteinase associated with cells of the trophectoderm 
(Perona and Wassarman, 1986). In the cow, there is no evidence of an enzymatic 
mechanism during hatching since zona pellucida-intact embryos, as well as empty ZP, 
can be found from uterine flushings up to day 16 after ovulation (Betteridge et al., 1980). 
These findings suggest that in the cow, hatching of the fully expanded bovine blastocyst 
occurs through an increase in hydrostatic pressure in the blastocoele cavity which is 
followed by rupture of the ZP.  
Several studies during in vitro blastocyst expansion and hatching have observed 
one or more partial or total collapse(s) of the blastocoele cavity followed by re-expansion 
of the blastocoele. This pulsatile activity has been observed in various species including 
rabbit (Lewis and Gregory, 1929), mouse (Cole, 1967), and cow (Massip and Mulnard, 
1980). The origin and possible roles of these collapses are unknown; however, excessive 
pulsatility might be related with poor embryo viability due to the fact that blastocyst 
exhibiting frequent collapses failed to hatch (Massip and Mulnard, 1980).  In a recent 
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study (van Heule et al., 2001), the effect of serum supplementation on pulsatile activity 
and hatching of in vitro produced bovine blastocyst was investigate by time-lapse 
cinematography. Addition of serum increased pulsatile activity before ZP rupture, 
reduced the time of hatching and increased hatching rates when compared to embryos 
cultured in the same medium but without serum supplementation. Moreover, pulsatile 
activity was not involved in the hatching process due to the fact that blastocyst showing 
no collapses hatched. Finally, hatching occurred at various times post insemination 
(average of 153h 35 min ± 1h 59 min) and at various embryo diameters (ranging from 
179 to 235 μm). 
 
11. Developmental differences between in vivo and in vitro embryos 
Before making inferences about similarities and differences between in vitro and 
in vivo-derived embryos, it worth noting that literature cited to prepare this discussion can 
be considered “old”,  with the majority of these publications published in the 90’. Since 
then, several changes on in vitro development of bovine embryos have occurred to more 
closely resemble the events occurring during in vivo development of bovine embryos in 
an effort to increase the quality of in vitro-derived embryos. 
The percentage of putative zygotes reaching the blastocyst stage after in vitro 
production (IVP) of embryos is only 20 to 30% (Thompson and Duganzich, 1996). In 
addition to this poor developmental capacity, in vitro-derived embryos present lower 
quality than those derived from in vivo. In an attempt to determine such differences, Van 
Soom and Kruif (1992) cultured in vivo-derived zygotes and 2-cell stage embryos and in 
vitro-derived putative zygotes under identical conditions. In this study, in vivo-derived 
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zygotes and early embryos cleaved and developed better than in vitro-derived putative 
zygotes (84.3 vs. 62% cleavage and 69 vs. 35% development, respectively). Moreover, in 
vivo-derived embryos compacted better and presented better blastomere morphology 
(rounded vs. square and swollen) than in vitro counterparts.  In addition to this, Iwasaki 
and Nakahara (1990) reported that allocation of cells to the inner cell mass is lower at the 
blastocyst stage for in vitro-derived embryos. In fact, Van Soom et al. (1997) 
demonstrated that rapid transition between morula to blastocyst stage of in vitro-derived 
embryos is responsible for lowering the numbers of cells at the inner cell mass of the 
embryo. To the contrary, the longer transition from morula to blastocyst stage of in vivo-
derived embryos allows sufficient time for allocation of inner cells to the inner cell mass 
of the embryo.  
Other differences between in vivo and in vitro embryos include chromosomal 
abnormalities, morphology under electron microscopy, embryo metabolism, gene 
expression and survival after handling and freeze/thawing techniques. Conditions utilized 
during in vitro production of embryos affected the incidence of chromosomal 
abnormalities, from 7-10% in in vivo- to 15% in in vitro-derived embryos (Kawarsky et 
al., 1996). Moreover, under electron microscopy, in vitro-produced embryos were 
characterized by a lack of desmosomal junctions, a reduction of surface microvilli, an 
increase in the number of lipid droplets, mitochondrial degeneration, and cytoplasmic 
vacuolation (Shamsuddin and Rodriguez-Martinez, 1994; Rizos et al., 2002). Compared 
with their in vivo counterparts, in vitro-produced embryos tend to have darker cytoplasm 
and a lower buoyant density as a consequence of their higher lipid content (Pollard and 
Leibo, 1994) and a more fragile zona pellucida (Duby et al., 1997). With regard to 
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embryo metabolism, ATP production, oxygen uptake and glucose uptake between in vivo 
and in vitro-derived embryos appear to be the same (Thompson et al., 1996). On the other 
hand, glucose oxidation (Thompson et al., 1991) and amino acid uptake (Partridge and 
Leese, 1996) for in vitro-derived embryos appeared to be lower than in vivo-derived 
embryos. The quality and cryotolerance of in vivo-derived embryos are higher than 
embryos produced in vitro. These differences may be explained by differences in gene 
expression and lipid content between these two groups of embryos.  
Recent studies have shown that development of in vitro-derived embryos depends 
upon developmental competence of the oocyte (Rizos et al., 2002); however, the post-
fertilization culture environment is known to be the most important factor determining  
quality of resulting embryos (Rizos et al., 2002; Rizos et al., 2003). Several studies have 
reported expression patterns of developmentally competent genes in preimplantation 
bovine embryos (Wrenzycki et al., 1996; Wrenzycki et al., 1998, 1999; Lazzari et al., 
2002; Rizos et al., 2002; Rizos et al., 2002; Wrenzycki et al., 2003; Mohan et al., 2004; 
Tesfaye et al., 2004; El-Halawany et al., 2005); however, the end point of these studies 
has generally been measured in blastocyst stage embryos. Lonergan et al. (2003), in an 
attempt to determine temporal divergence in mRNA expression of in vitro and in vivo-
cultured bovine embryos, reported that changes in gene expression are strongly 
influenced by the culture environment and that changes in the amount of mRNA in 
blastocyst stage embryos are a consequence of lowered transcription earlier in 
development. In a similar study, Tesfaye et al. (2004) also reported temporal divergences 
in mRNA between in vivo and in vitro-derived bovine embryos. These findings are in 
agreement with those from Rizos et al. (2002; 2003), where culture medium of in vitro 
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produced embryos determined quality of resulting embryos measured in terms of their 
cryotolerance and relative abundance of transcripts. Moreover, Lazzari et al. (2002) 
demonstrated that in vitro culture of bovine embryos using animal proteins (bovine serum 
albumin, BSA) alters kinetics of embryo development (greater amount of cells and 
overall size), the expression of developmentally important genes, and when transferred to 
suitable recipients, resulted in higher birth weight of calves compared to embryos 
produced in vivo. Furthermore, when embryos were cultured in medium without BSA 
(replaced by polyvinyl alcohol, PVA), gene expression patterns resembled that of in vivo-
derived embryos. Therefore, alterations in gene expression of in vitro-produced embryos, 
caused by the culture environment, are probably responsible for lowering the quality of 
these embryos when compared to the quality of in vivo-derived embryos. 
 
12. Synthesis of prostaglandins 
Prostaglandins are involved in several physiological processes such as 
inflammation, production of pain and fever (Seibert et al., 1994; Blatteis and Sehic, 
1997), control of blood vessel tone and arterial blood pressure (Nett et al., 1976), 
luteolysis (Goding, 1974), muscle growth and differentiation (Horsley and Pavlath, 
2003), and blood clotting (Moncada and Vane, 1981). With exception of red blood cells, 
prostaglandins are synthesized and released by all mammalian cells and tissues. 
However, unlike other hormones, prostaglandins are not stored in cells but are produced 
and released immediately after synthesis (Bito, 1975).  
Phospholipase A2 (PLA2) enzymes catalyze hydrolysis of the sn-2 position of 
membrane glycerophospholipids to liberate arachidonic acid (AA), a precursor of 
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prostaglandins, tromboxane A2, and leukotrienes. So far, at least 19 enzymes that possess 
PLA2 activity have been identified in mammals (reviewed by (Murakami and Kudo, 
2004). Since arachidonic acid contains 20 carbon atoms, prostaglandins are referred as 
eicosanoids.  
The formation of PGF2α begins with release of the precursor of all prostaglandins, 
arachidonic acid (AA), from the sn-2 position of membrane phospholipids principally by 
the action of the cytosolic, high molecular weight, calcium-dependent phospholipase A2 
(cPLA2; (Flint et al., 1986), but also by the action of phospholipase C (PLC), 
phospholipase D (PLD), and mono- and diacy-glycerol lipases (Flower and Blackwell, 
1976; Irvine, 1982; Kozawa et al., 1997; Kozawa et al., 1997). Cleavage of AA from 
membrane phospholipids is the rate-limiting step in prostaglandin synthesis. Several 
phospholipases A2 (PLA2s) can release AA from membrane phospholipids (as reviewed 
by (Khan et al., 1995; Capper and Marshall, 2001). These PLA2s are basically divided in 
two groups: 1) Low molecular weight PLA2s (the largest group): are secreted to the 
extracellular space and their activity depends on high levels of calcium. Their functions 
are not very well known with the exception of the IIA and IB PLA2s. Phospholipase IIA 
has direct bactericidal effect on gram-negative bacteria, whereas PLA2IB (also called 
pancreatic PLA2) participates in lipid digestion. The other group 2) High molecular 
weight PLA2s are constituted by intracellular PLA2s, that are also divided in calcium-
dependent (cPLA2α or IVA cPLA2, cPLA2β or IVB cPLA2) and calcium-independent 
PLA2 (VIA iPLA2 and IVC cPLA2) 
Arachidonic acid released by the action of PLA2s is converted to prostaglandin H2 
(PGH2) by the action of cyclooxygenase enzymes-1 or -2 (COX-1 and COX-2) at the 
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membrane of the endoplasmic reticulum (Smith and Dewitt, 1996) or at the nuclear 
envelope (Parfenova et al., 2001).  Cyclooxygenase-1 is a constitutive enzyme found in 
almost all cells (O'Neill et al., 1994), whereas COX-2 is an inducible form in response to 
inflammatory reactions, hormonal and environmental stimulus (Smith and Dewitt, 1996). 
Conversion of AA to PGG2 is performed in two sequential enzymatic steps: oxygenation, 
which converts free arachidonic acid to the unstable intermediate PGG2, followed by a 
peroxidation that converts PGG2 to PGH2 (Smith and DeWitt, 1996). These two 
enzymatic reactions (oxygenation and peroxidation) are catalyzed by the enzymes 
cyclooxygenase-1 and –2 (COX-1 and COX-2). Finally, PGH2 is transformed into PGF2α 
by tissue-specific prostaglandin F2α synthase (Watanabe et al., 1985).  Following its 
synthesis, PGF2α is transported out of the cell by a prostaglandin transporter (Chan et al., 
1998) where it exerts an autocrine or paracrine function through its G protein coupled 
receptor. Catabolism of PGF2α is accomplished by the enzyme prostaglandin 15-
dyhydrogenase (PGDH), which converts PGF2α into the inactive PGF2α metabolite, 
PGFM (Keirse et al., 1978).  
Different specific enzymes, whose presence varies depending on the cell type, 
mediate formation of the D, E, I, and F series from PGH2 in different tissues. Synthesis of 
prostaglandins can be blocked by administration of nonsteroidal anti-inflammatory drugs 
(NSAIDs) such as aspirin, flunixin meglumine, indomethacin and phenylbutazone and by 
steroidal anti-inflammatory drugs like hydrocortisone, prednisone and prednisolone. 
Nonsteroidal anti-inflammatory drugs act through inhibition of COX-1 and COX-2 (Vane 
and Botting, 1996), while steroidal anti-inflammatory drugs interfere with mobilization of 
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arachidonic acid from the plasma membrane by inhibition of phospholipase A2 (Rothhut 
and Russo-Marie, 1984). 
 
13. Mechanism of action of prostaglandin F2α
Prostaglandin F2α interacts with its G protein coupled receptor at the cell 
membrane and activates Gq Protein/phospholipase C (PLC-β)/Calcium release/Protein 
Kinase C (PKC) signaling pathway (Wiltbank et al., 1989; Wiltbank et al., 1990; 
Abramovitz et al., 1994; Sugimoto et al., 1994; Sales et al., 2004). G protein receptors 
contain 3 subunits called α, β, and γ (Findlay et al., 1993). The β and γ subunits remain 
together and are usually referred as the Gβγ subunit, whereas the α subunit is referred to 
the Gα subunit as reviewed by Findlay et al. (1993). Following PGF2α binding to its Gq 
protein-coupled receptor (Lee et al., 1987), the Gα subunit suffers a conformational 
change that allows exchange of GDP for GTP and dissociation of the Gα from the Gβγ 
subunit. Next, the Gα subunit binds to PLC-β causing its activation. After activation of 
PLC-β, the intrinsic GTP-ase activity of the Gα subunit hydrolyzes bound GTP to GDP 
and dissociates from PLC-β allowing re-association of the Gα subunit with the Gβγ 
subunits (inactive Gq form). Next, PLC-β cleaves phosphatidyl inositol 4,5 bisphosphate 
(PIP2) into two second messengers: diacylglycerol (DAG), that remains associated to the 
plasma membrane and inositol 1,4,5 trisphosphate (IP3) that diffuses to the cytoplasm. 
Inositol trisphosphate releases calcium from the endoplasmic reticulum to the cytosol 
(Berridge, 1993).  
The increase of intracellular calcium levels recruits PKC to the cell plasma 
membrane where DAG causes its activation. Protein Kinase C phosphorylates several 
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other proteins involved in cellular growth and metabolism. Exposure of bovine luteal 
cells and osteoblasts to PGF2α activates Raf/MEK/MAPK signaling cascade (Chen et al., 
1998). Mitogen activated protein kinases (MAPK) form homodimers that translocate to 
the nucleus where they regulate activity (through phosphorylation) of many nuclear 
transcription factors such as TCF or SRF (reviewed by (Hunter, 2000). Phosphorylated 
TCF and SRF form a transcription factor complex that binds to SRE in DNA and 
stimulate gene transcription of c-fos and c-jun genes (Chen et al., 2001). In addition, Gq 
protein may not be the only G-protein involved in induced MAPK activation, since 
studies involving pertussis toxin (a selective inhibitor of G-protein Gi) demonstrated 
inhibition of PGF2α -dependent MAPK stimulation by this toxin (Melien et al., 1998). In 
agreement with this, Gi βγ subunits mediated activation of MAPK in PGF2α -stimulated 
uterine myometrial cells (Melien et al., 1998). Mitogen activated protein kinases were 
directly activated through Ras or indirectly activated by the formation of the Shc, Grb2 
and SOS complex leading to activation of Ras followed by activation of the 
Raf/MEK/MAPK signaling cascade. Furthermore, PGF2α-induced proliferation of 
neoplastic human endometrial cells by activating MAPK signaling via PLC-β and trans-
activation of the epidermal growth factor receptor (EGFR; (Sales et al., 2004). Lastly, the 
increase in cytosolic calcium by IP3 and activation of PKC can lead to activation of other 
protein kinases such as PI3K, p38 and Junk, which can also mediate cellular responses.  
The bovine CL represents an excellent model for understanding the mechanisms 
of action of PGF2α. Protein Kinase C is believed to mediate many of the antisteroidogenic 
actions of PGF2α in large luteal cells (McGuire et al., 1994). In addition to this, PGF2α 
may interfere with ability of LH to activate PKA, an enzyme needed for phosphorylation 
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and stimulation of other key enzymes in the luteal steroidogenic pathway, such as 
cholesterol esterase (hydrolyzes the stored cholesterol) and steroidogenic acute regulatory 
protein (StAR), which transports cholesterol to the mitochondria (Garverick et al., 1985). 
In contrast to early signaling events, downstream signals in response to PGF2α are poorly 
understood. Chen et al. (1998) reported that PGF2α activates the Raf/Mek1/mitogen-
activated protein kinase (MAPK) signaling cascade in bovine luteal cells. Therefore, 
signals on the cell surface may be responsible for transcription of luteal genes. 
Prostaglandin F2α promotes apoptosis in luteal cells by activation of endonucleases after 
influx of Ca++ from intracellular stores (Juengel et al., 1993). Also during luteolysis in 
cattle, mRNA encoding Bax (a pro-apoptotic gene) is elevated resulting in an increased 
ratio of Bax to Bcl-2 (anti-apoptotic gene), an event consistent with Bax-mediated 
apoptosis (Rueda et al., 1997). Prostaglandin F2α induces apoptosis in luteal cells by 
generation of oxygen radicals such as superoxide anion, hydroxyl radical and hydrogen 
peroxide (Riley and Behrman, 1991; Carlson et al., 1993). Exposure of rat luteal cells to 
these oxidants resulted in oxidation and loss of fluidity in cellular membranes (Sawada 
and Carlson, 1991). Decreased membrane fluidity affects cellular function including 
receptor binding and membrane-bound enzyme activity as demonstrated by Wu et al. 
(1992), who suggested that superoxide radical production inhibited LH stimulation of 
cyclic AMP and decreased activity of protein kinase A.  In pigs, PGF2α depleted the CL 
of vitamin C, a natural antioxidant that prevents oxygen radical formation (Petroff et al., 
1999). 
Prostaglandin F2α is a potent, bioactive compound. As such, its production and 
metabolism must be tightly regulated. The lungs appear to play an important role in 
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inactivating prostaglandins. In the ewe, PGF2α in the blood stream has a half-life of less 
than 1 min, since 99% of it is metabolized to 13, 14-dihydro-15-keto-PGF2α (PGFM) in a 
single passage through the lung (Hansel and Dowd, 1986). In the cow, only 16% of 
PGF2α remained in the blood after three passages through the lung (Davis et al., 1984). 
 
14. Prostaglandin F2α receptor 
Prostaglandin F2α receptors (FPr) have been cloned from cattle (Sakamoto et al., 
1994), sheep (Graves et al., 1995), mouse (Sugimoto et al., 1994), rat (Kitanaka et al., 
1994) and human (Abramovitz et al., 1994) cDNA libraries. In the cow and ewe, the 
clones encode for 362 amino acids residues in the open reading frame (Sakamoto et al., 
1994; Graves et al., 1995); while in mouse and rat, FPr have 366 amino acids (Kitanaka 
et al., 1994; Sugimoto et al., 1994) and human FPr consist of 359 amino acids 
(Abramovitz et al., 1994). The molecular weight of the FPr is similar between species, 
with estimated molecular weights ranging from 40 (humans) to approximately 41 KDa 
(bovine). The hydropathy profile indicates that the deduced amino acid sequence consists 
of seven hydrophobic segments, representing seven transmembrane helices, a structure 
common to known prostanoids receptors and other G protein-linked receptors. The amino 
acid sequences of FP receptors are very similar between different species. For example, 
the bovine FPr (Sakamoto et al., 1994) shares 98% homology with the ovine FPr (Graves 
et al., 1995), 86% with the human (Abramovitz et al., 1994), 80% with the mouse FPr 
(Sugimoto et al., 1994), and 78% with the rat FPr (Kitanaka et al., 1994). Sequence 
homology between species is highly conserved in the transmembrane domains of the FPr 
protein. In contrast, the NH2-terminal and COOH-terminal regions show considerable 
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sequence diversity. The NH2-terminal region contains two potential N-glycosylation sites 
as observed with other members of the G protein coupled receptor family (Hubbard and 
Ivatt, 1981). Several serine and threonine residues, potential phosphorylation sites for 
protein kinase C, are commonly conserved in the COOH-terminal region or in the second 
intracellular loop (Sakamoto et al., 1994). Sequence comparisons of the FPr and other 
members of the prostanoids receptor family reveal significant homologies between them. 
For example, the bovine FPr shares 34, 33, and 36%  amino acid sequence homology 
with the human, mouse, and bovine TXA2 receptors, respectively (Sakamoto et al., 
1994). Similarly, the bovine FPr shares 31 and 32% homology with the bovine and 
mouse EP3 receptors (Sakamoto et al., 1994). It is worth noting that these homologies are 
mostly localized to transmembrane domains, particularly domain VII. 
In order to elucidate the mechanisms of receptor-ligand interactions at the 
molecular level, Sakamoto and coworkers (1995) constructed a model for the bovine FPr 
based on its amino acid sequence, the known helical arrangement of rhodopsin (a G-
protein coupled receptor; (Findlay et al., 1993), and a model of the human TXA2 receptor 
(Yamamoto et al., 1993). The authors concluded that the ligand binding pocket of the FPr 
includes argenine-291 and a large hydrophobic pocket. The carboxylic acid group of 
PGF2α may interact with arginine-291. The C-9 and C-11 hydroxyl groups of the PGF2α 
may interact with the serine and threonine residues in the transmembrane domains III and 
VII, respectively. Another amino acid, histidine-81, in the transmembrane domain II, may 
also be important for PGF2α binding as shown in transfection studies with mutant rat FPr 
expressed in COS-7 cells (Rehwald et al., 1999). This may be explained in part by the 
close proximity of histidine-81 to arginine-291 and also by the ability of histidine as an 
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hydrogen bond donor (Rehwald et al., 1999; Anderson et al., 2001). Cysteine residues 
(Cys-109 and Cys-186) in the first and second extracellular loops of the FPr are likely to 
form a disulfide bond that stabilizes the protein structure (Probst et al., 1992; Abramovitz 
et al., 1994; Lake et al., 1994). These two cysteines are highly conserved among all 
prostanoids receptors and many other G-protein coupled receptors (Probst et al., 1992). 
 
15. Gene structure and regulation of the FPr 
The gene size of the FPr is approximately 10, 11 and 40 kilobases in humans, 
mouse and cow, respectively (reviewed by Anderson et al., 2001). The FPr gene is 
located in chromosome 1 in humans (Duncan et al., 1995) and near the gene for  
prostaglandin E receptor-subtype 3 in chromosome 3 in mice (Ishikawa et al., 1996). The 
exon/intron organization of the FPr gene is conserved among humans (Betz et al., 1999) 
and cattle (Ezashi et al., 1997). 
All known members of the prostaglandin receptor family have similar 
organization of exons and introns (Ogawa et al., 1995) and support the idea of a common 
origin from a single ancestor gene. In humans and cattle, the FPr gene contains three 
exons and 2 introns with translated regions localized at exons 2 and 3 (Ezashi et al., 1997; 
Betz et al., 1999). The first exon is the smallest (164 and 194 base pairs in humans and 
cattle, respectively) and includes most of the 5’ untranslated region. The second exon 
(approximately 870 base pairs for both species) contains a small fraction of untranslated 
region and the majority of translated region for the receptor. The third and largest exon 
(1459 and 3977 base pairs in humans and cattle, respectively) includes the remainder of 
the translated region and a large untranslated region. 
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Multiple transcription initiation sites have been identified in mouse and bovine 
FPr gene. In the mouse, the major transcription site is located at the 5’ end of exon 1, 232 
bp upstream of the ATG that marks the translation start site. In the bovine, multiple 
transcription initiation sites were identified in exon 1. In addition, other minor 
transcription initiation sites were identified in intron 1 (reviewed by (Anderson et al., 
2001). 
Two potential promoter regions were identified in the bovine FPr gene (Ezashi et 
al., 1997). A 1.6-kb region upstream of exon 1 contained sequences for the transcription 
factors: TRE/AP-1 (TPA-responsive element/activator protein-1), NF-IL6 (nuclear 
factor-interleukin 6), Sp 1, and GCF (GC binding factor). The second potential promoter 
in intron 1 contained sequences for Sp 1, TRE/AP-1, CRE (cyclic AMP-responsive 
element), NF-IL6, and AP-2 (activator protein-2) as well as CAAT-like and TATA-like 
boxes (Ezashi et al., 1997). The activities of these two promoters were investigated by 
Ezashi et al. (1997) after transfecting bovine luteal cells with these promoters linked to a 
reporting luciferase gene. Treatment of transfected cells with TPA (a phorbol ester 
known to activate protein kinase C), but not with forskolin (an activator of protein kinase 
A), resulted in transcriptional activation of the luciferase gene. It is well known that TPA 
directly activates protein kinase C (Comb et al., 1986) and that PKC can modulate the 
activity of nuclear transcription factors such as AP-1, which can increase gene expression 
by binding to TRE. In contrast to the findings of Ezashi and coworkers (1997), Tsai and 
colleagues (1998) reported that phorbol ester and forskolin decreased and increased FPr 
mRNA concentration in ovine luteal cells, respectively. These results also agreed with 
several other studies (Sakamoto et al., 1995; Juengel et al., 1996; Mamluk et al., 1998; 
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Hoyer et al., 1999) and suggest that additional regions of the genome are needed to 
regulate transcription of the FPr gene.    
 
16. Messenger RNA for FPr 
Several studies have identified expression of FPr mRNA using Northern Blot 
hybridization and polymerase chain reaction techniques. Although a great variety of 
tissues express FPr mRNA in ovine, the steady-state concentration of FPr was highest in 
the corpus luteum with quantities of FPr mRNA at least 100-fold greater than any other 
tissue (Tsai et al., 1998). In the corpus luteum, mRNA coding for the FPr is localized 
mostly on large luteal cells of bovine and ovine mid cycle corpora lutea (Fitz et al., 1982; 
Juengel et al., 1996). In fact, Tsai and coworkers (1998) revealed that the concentration 
of FPr mRNA was greater in large luteal cells compared with small luteal cells. Large 
luteal cells contained 7,314 ± 829 copies of FPr mRNA per cell, whereas small luteal 
cells contained 226 ± 54 copies per cell. 
Expression of FPr mRNA in the corpus luteum was shown to progressively 
increase during the estrous cycle, but was markedly reduced upon luteal regression 
(Sakamoto et al., 1995). In addition, constant amounts of FPr mRNA were observed in 
early and middle pregnant corpus luteum, with a significant reduction by late pregnancy 
(Sakamoto et al., 1995). The expression of FPr mRNA was decreased by treatment of 
ewes with PGF2α or by treatment of large luteal cells with PGF2α in vitro (Tsai et al., 
1998). Therefore, mRNA encoding FP receptor appears to be downregulated by its 
homologous ligand. In fact, the number of FPr in corpus luteum from non-pregnant sheep 
has been shown to decrease at the time of luteolysis (Wiepz et al., 1992). Several other 
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studies have shown a decrease of FPr after PGF2α administration or natural luteolysis in 
cattle (Sakamoto et al., 1995), ovine (Hoyer et al., 1999), and pigs (Estill et al., 1995). In 
contrast, the FPr mRNA was increased after treatment of rats with a PGF2α analogue 
(Olofsson et al., 1996), which will indicate specific species differences in the regulation 
of the FPr mRNA. 
 
17. Prostaglandin F2α receptor isoforms 
Prostaglandins, are ubiquitously produced and act locally in an autocrine or 
paracrine manner by binding to G-protein coupled receptors (Findlay et al., 1993; Hata 
and Breyer, 2004). All eight prostanoid receptors identified to date (TP: tromboxane 
receptor; DP; prostaglandin D receptor; EP: prostaglandin E receptor [EP1, EP2, EP3, 
EP4]; IP: prostaglandin I receptor, and FP: prostaglandin F receptor) are integral 
membrane proteins that possess seven transmembrane domains (α helices). These 
receptors are coupled to specific G proteins mediating the formation of second 
messengers such as cAMP, DAG and inositol trisphosphate (IP3; as reviewed by Tsuboi 
and coworkers, (2002). The extracellular parts of the receptor can be glycosylated or 
form disulfide bonds between highly conserved cysteine residues to stabilize the receptor.  
The intracellular loops between α helices 5 and 6 and the C-terminal segment are 
important for interactions with G proteins. The prostanoids receptors are classified 
according to the prostanoid ligand that each binds with greatest affinity. Recently, a ninth 
prostaglandin receptor, CRTH2, was identified on Th2 cells (Hirai et al., 2001).   
Two differentially spliced variants of the sheep FP receptor have been reported, 
the original FPr re-named FPA and a truncated form called FPB (Pierce et al., 1997). 
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These variants exhibit similar ligand binding profiles and G protein coupling preferences 
(Pierce et al., 1997). However, the C terminal tail of the FPA, but not the truncated FPB, 
can be phosphorylated by PKC, leading to agonist-induced desensitization and 
internalization (Fujino et al., 2000). In contrast, FPB does not undergo agonist-induced 
internalization but instead experiences constitutive internalization (Srinivasan et al., 
2002). In addition, both isoforms are able to stimulate IP3 accumulation to the same 
maximum, but the basal level of hydrolysis is 130% higher for the FPB than the original 
FPA isoform (Pierce et al., 1997).  
Another type of FP receptor isoform, FPa, has recently been cloned in bovine 
(Ishii and Sakamoto, 2001). FPa is generated by alternative splicing at the middle of the 
sixth transmembrane domain, resulting in the lack of a seven transmembrane domain and 
an intercellular carboxyl tail. Transfected cells with FPa failed to stimulate PKC after 
treatment with PGF2α; whereas, cotransfection of an excess amount of FPa markedly 
reduces the original FP-mediated PKC response, suggesting that FPa could play a role as 
a negative regulator to attenuate normal FPr function (Ishii and Sakamoto, 2001).  
Recently, Sakamoto et al. (2002) identified the cDNA clones for five novel FPr 
isoforms from a bovine corpus luteum cDNA library. The sequence analysis revealed that 
these clones encoded the amino acid sequences of the original FPr (Sakamoto et al., 
1994) and the following clone-specific regions. Because only one copy of the FPr gene 
has been identified in the bovine (Ezashi et al., 1997), these clones named FP-α, FP-β, 
FP-γ, FP-δ, and FP-ε were identified as novel FPr isoforms generated by alternative 
mRNA splicing. These proteins are constituted of 325, 326, 339, 293, and 298 amino 
acids, respectively. These isoforms can be classified based in the location of the splicing 
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site into two groups. FP-α, FP-β, FP-γ can be potentially spliced within the fourth 
intracellular C-tail. These isoforms can be classified into the same group (Type I), which 
is composed of the common overall sequences from the N-terminus through 
transmembrane segment VII and the isoform-specific tail. The other isoforms, FP-δ and 
FP-ε, are classified into the second group (Type II), which contains the variation from the 
fourth extracellular domain through the C-tail. Hydrophobicity analysis revealed that 
Type I isoforms possess intact seven transmembrane domains, while the Type II isoforms 
carry truncated structures lacking transmembrane domain VII and the intracellular C-tail 
(Sakamoto et al., 2002). In fact, the C-terminal region of the Type II isoforms may be 
buried in the plasma membrane or protrude into the extracellular region and therefore 
their ability to interact with G proteins and stimulate a cell signaling cascade would be 
totally inhibited. As previously demonstrated by Ishii et al. (2001), these Type II isoforms 
may function as suppressors for the normal activation of PKC after PGF2α binding to the 
original FPr. The mRNA of these novel FPr isoforms and the original FPr isoforms were 
shown to be expressed in the bovine corpus luteum at the same time during the estrous 
cycle and pregnancy (Sakamoto et al., 2002). This suggests a cooperative role of these 
isoforms with the original FP during the estrous cycle and pregnancy.   
 
18. Prostaglandin F2α receptor agonists and antagonists 
Development of potent and selective FP receptor agonists has resulted in the 
ability to investigate specific cellular responses coupled to the activation of these 
receptors (for example, activation of phospholipase C, increases in intracellular levels of 
calcium and activation of PKC). Some of the FPr agonists include bimatoprost, 
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latanoprost and travoprost (Sharif et al., 2002). These substances possess similar 
chemical structures and shapes as the endogenous ligand and therefore are able to bind to 
the receptor and trigger a cellular response by “mimicking” the interaction of the 
endogenous ligand to the receptor (Jasper and Insel, 1992). Agonists can be classified as 
full or partial agonists (Jasper and Insel, 1992). A partial agonist binds to the specific 
receptor, but does not cause as much of a physiological change as does a full agonist 
(Franciosa, 1989). Moreover, a partial agonist can bind to a large number of receptors 
and competitively inhibit action of a full agonist for the same receptor (Franciosa, 1989).  
Antagonists for the FPr are being used to positively identify FPr mediating 
functional responses in vitro or in vivo. Some FPr antagonists include AL-3138, AL-
8810, PGF2α dimethylamine, dimethylamide, glibenclamide and phloretin (Griffin et al., 
1999; Sharif et al., 2000). Antagonist substances bind to receptors and do not produce 
any physiological responses. Antagonists are classified as competitive antagonists or non-
competitive antagonists. Competitive antagonists compete with the endogenous ligand/s 
for the active site of the receptor. Once the antagonist is bound to the receptor, it does not 
produce any physiological response in the cell and does not allow the endogenous ligand 
to bind to the same receptor. Competitive antagonists produce a concentration dependent 
shift in the endogenous ligand concentration-response curve, without decreasing the 
agonist-induced maximal response. Another effect of a competitive antagonism is the 
increase in the Kd of an agonist when increasing concentrations of the competitive 
antagonist. An example of this is the effect of AL-8810 concentration on the 
concentration-response curves of fluprostenol, a full agonist of the FP receptor (Sharif et 
al., 2002). Griffin et al. (1999) characterized the pharmacological activities of AL8810 at 
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the FP receptor. Authors concluded that previous exposure of mouse fibroblast to AL-
8810 abolished the production of IP3 associated to FPr stimulation by FPr agonist 
(fluprostenol) or its endogenous ligand (PGF2α). In addition, AL-8810 did not have any 
antagonistic activity at several other prostanoid receptors such as TP, DP, EP2 and EP4. 
In agreement with these findings, several other studies indicated that AL-8810 inhibited 
production of IP3 after activation of FPr (Sharif et al., 2002; Kelly et al., 2003; Sharif et 
al., 2003; Sharif et al., 2003). During non-competitive antagonism, an antagonist binds to 
its receptor on a different site from the endogenous ligand. In this case, binding of the 
antagonist does not block the endogenous ligand binding (or vice versa), but the receptors 
can not get activated when the antagonist is bound to it. The antagonist also lowers the 
concentration of free ligand and has no effect on the Kd for the agonist.  
 
19. Prostaglandin F2α association with early embryonic loss 
The first indications that PGF2α were involved in embryonic loss occurred in a 
series of experiments in the “short cycle” cow at West Virginia University. In the 
postpartum cow, the first ovulation is followed by a short luteal phase (short cycle) due to 
premature release of PGF2α (Cooper et al., 1991). Cows with short luteal phase failed to 
maintain pregnancy even when exogenous progestogen was provided (Breuel et al., 
1993). Moreover, when good quality frozen-thawed embryos were transferred to 
progestogen-supplemented animals on day 7 after estrus, pregnancy was maintained in 
28% of short cycle cows compared to 58% of cows with normal luteal phase (Butcher et 
al., 1992). However, pregnancy rates did not differ when day-6 embryos from short cycle 
or normal cycling cows were transferred to normally cycling recipients (Schrick et al., 
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1993), suggesting that an improper uterine environment appears to play a role in lower 
survival of embryos in cows with short cycle as compared to cows with normal luteal 
phases. Schrick et al. (1993) observed that concentrations of PGF2α in flushing media 
from cows with short luteal phases were more than double those from cows with normal 
luteal phases (636 ± 82 and 288 ± 90 pg/ml, respectively). Furthermore, embryo quality 
tended to be negatively correlated with concentrations of PGF2α in the flushing media (r 
= -0.42; P=0.07). Thus, a direct negative effect of PGF2α may be implicated in lowering 
embryonic survival as demonstrated in vitro in the mouse (Harper and Skarnes, 1972), 
rabbit (Maurer and Beier, 1976), and rat (Breuel et al., 1993). 
Effects of PGF2α on embryo survival have been examined in several studies using 
progestogen-supplemented cows to replace the regressing corpus luteum. Buford et al. 
(1996) demonstrated that PGF2α was detrimental to embryonic survival when 15 mg of 
PGF2α every 8 h was injected to non-lactating cycling beef cows during days 4 through 7 
or 5 through 8 after insemination, but pregnancy rates remained high when lutectomy 
(removal of the corpus luteum) was performed before PGF2α treatment begun. Similarly, 
PGF2α administration to progestogen-supplemented beef cows on days 5 to 8 
postbreeding reduced pregnancy rates (23%) compared to control (72%), whereas 
lutectomy prior to PGF2α administration tended to improve pregnancy rates (55%; Seals 
et al., 1998). Removal of the corpus luteum eliminates oxytocin release from the corpus 
luteum and blocks the positive feedback loop between oxytocin and PGF2α. As a result, 
PGF2α concentration in the uterine lumen would remain low, allowing embryonic 
development to occur.  Furthermore, Seals et al. (1998) reported that detrimental action(s) 
of PGF2α occurred during early embryonic development (days 5 to 8) since 
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administration of PGF2α during filamentous embryo development (beyond day 10) had no 
effect on maintenance of pregnancy.  
Buford et al. (1996) demonstrated that postpartum cows bred at their first estrus 
after weaning had higher pregnancy rates when lutectomy was used in conjunction with 
flunixin meglumine (an inhibitor of COX-1 and COX-2), but lutectomy alone failed to 
maintain pregnancy rates. The authors suggested that both premature secretion of PGF2α 
and a factor released by the regressing corpus luteum may contribute to embryonic death 
in the postpartum cow with a short luteal phase. 
 Oxytocin, which is released by large cells of the regressing corpus luteum in 
response to PGF2α, can increase secretion of PGF2α from the uterus (Milvae and Hansel, 
1980). Lemaster et al. (1999) treated progestogen-supplemented cows with oxytocin 
rather than PGF2α in the same type of experiment performed by Seals et al. (1998). 
Administration of oxytocin on days 5 through 8 every 8 h reduced pregnancy rates to 
33% compared to the control group (80%). In the same study, administration of flunixin 
meglumine blocked the negative effects of oxytocin, while lutectomy did not; thus, the 
role of oxytocin on embryonic death may involve further release of PGF2α rather than 
having a direct negative effect on the embryo. 
Numerous factors such as heat stress (Putney et al., 1989; Malayer et al., 1990), 
nutrition (Butler, 1998), mastitis (Hockett et al., 2000), manipulation of the reproductive 
tract during embryo transfer and artificial insemination (Odensvik et al., 1993; Scenna et 
al., 2005), and plant toxins (Woclawek-Potocka et al., 2005) may contribute to early 
embryonic losses (before day 8) through premature release of uterine luminal 
concentrations of PGF2α in cattle. Administration of flunixin meglumine or ibuprofen 
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lysinate (inhibitors of COX-1 and COX-2) at time of embryo transfer improved 
pregnancy rates in cows (Elli et al., 2001; McNaughtan et al., 2002; Pugh et al., 2004; 
Purcell et al., 2004; Scenna et al., 2005). Furthermore, low-dose aspirin treatment 
improved implantation and pregnancy rates in human patients undergoing in vitro 
fertilization and transfer (Rubinstein et al., 1999). Thus, in vivo and in vitro studies have 
shown that PGF2α decreased embryonic development and survival in several species. 
 
20. Embryo transfer  
The objective of a multiple ovulation and embryo transfer (MOET) program in 
livestock production is the rapid acquisition of superior genetics and to increase the 
productive life of superior donor cows by increasing the number of its valuable progeny 
through this technique (i.e. obtaining 20 transferable embryo per year resulting in 10 
pregnancies instead of only having one calf per year when not using ET).  Currently, the 
ET technique is widely used around the world, with more than 500,000 embryos being 
transfer annually (Thibier, 2000). Briefly, during any MOET program, the estrous cycle 
of a donor cow is synchronized, the growth of follicles in each ovary is stimulated by 
injecting follicle stimulating hormone (FSH), and the donor cow is observed for estrus 
and artificially inseminated with frozen semen 12 and 24 h after heat detection (Seidel, 
1981). Embryo recovery is performed seven days after estrus by placing a catheter 
through the cervix and up to the upper third of each uterine horn or in the uterine body 
(Drost et al., 1976). The uterus is flushed several times with phosphate buffered solution 
(PBS) containing antibiotics and bovine serum albumin or a synthetic surfactant such as 
polyvinyl alcohol (PVA) and the embryos are recovered in a filter. Next, embryos are 
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searched under a microscope, loaded in holding medium into 0.25 mL straws and transfer 
fresh to recipient cows or frozen in glycerol or ethylene glycol for future use.  
The first successful ET in mammals was recorded in 1891 using rabbit embryos 
(Heape, 1891). The next successful embryo transfer pregnancies resulted in rabbit 
(Pincus, 1930) and rat (Nicholas, 1933). The first ET calf was born following the surgical 
transfer of a slaughterhouse-derived 5-day old embryo (Willett et al., 1951). Commercial 
ET in cattle started in the early 1970’s, primarily as a result of the high prices paid for 
breeders for “exotic” beef cattle that had been imported in small numbers from Europe 
(Betteridge, 2000). This technique was done by mid-ventral surgical exposure of the 
uterus and ovaries with the donor under general anesthesia. Surgical ET was only 
possible in “in-house” programs with suitable facilities and in beef cows due to the fact 
that the udder of dairy cows hindered mid ventral access to the reproductive tract. 
However, the introduction of non-surgical embryo recovery (flushing) in the mid-1970’s 
(Elsden et al., 1976) and non-surgical embryo transfer in the late 1970’s (Bowen et al., 
1978) allowed ET to be practiced on the farm and in dairy animals. Prior to the early 
1980’s, the inability to freeze and thaw bovine embryos made it necessary to synchronize 
a sufficient number of recipient animals so that all recovered embryos could be 
transferred fresh. Fortunately, development of freezing protocols utilizing dimethyl 
sulfoxide or glycerol as cryoprotectants (Wilmut and Rowson, 1973) made ET more 
appealing to producers and a much more efficient technologicalley.  
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21. Efficiency and limitations of embryo transfer 
Efficiency of embryo recovery is probably between 70 to 90% (Seidel, 1984) and 
if no complications occur during uterine flushing (bleeding, clotting of the filter, cows 
going down in the chute, etc.) the procedure takes no longer than 30 min per cow. When 
performing ET, it is necessary to synchronize the estrous cycle of recipient cows with the 
estrous cycle of donor cows (Rowson et al., 1972; Lawson et al., 1975; Hasler, 2001). 
Asynchrony between donor and recipient estrous cycles greater that ± 24h resulted in 
poor pregnancy rates following ET (Hasler et al., 1987; Hasler, 2001). Moreover, if 
asynchrony between donor and recipient estrous cycles exists, then a synchrony between 
embryo stage with the day of estrous cycle of recipient cows should be made (Wright, 
1981; Lester and McNew, 1999). For example, morula stage embryos should be 
transferred to recipients on day 6 ± 12h after estrous detection and blastocyst stage 
embryos should be transferred to recipients on day 7 ± 12h after estrous detection. Today, 
pregnancy rates in beef cattle after non-surgical embryo transfer of in vivo-derived 
frozen-thawed (ethylene glycol) embryos is about 40 to 55% (Leibo, 1986; Malayer et al., 
1990; Nibart and Humblot, 1997; Lester and McNew, 1999), whereas pregnancy rate of 
those transferred fresh is about 55% to 80% (Hasler, 2001).   
The biggest problem in the embryo transfer industry is the variability in 
superovulatory response of donor cows (Seidel, 1984). The average of transferable 
embryos recovered per cow after a superovulatory treatment is in the range of 5 to 7 
(Donaldson and Perry, 1983; Hasler et al., 1983). However, many donors yield no 
transferable embryos or only a few, and in rare cases more than 30 transferable embryos 
are recovered (Seidel, 1984). In addition, administration of the same dose of FSH to the  
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same group of cows can result in cows  not responding at all and presenting small 
ovaries, cows responding accordingly to the expectations, and cows overstimulated with 
very large ovaries and often yielding no transferable embryos (Seidel, 1981). 
Superovulation can be performed every 60 days after allowing donor cows to have at 
least two estrous cycles between superovulations (Hasler, 2003). Recently, Hasler (2003) 
described a superovulation protocol called “donor quick turn around” that significantly 
reduces this interval. The protocol consists of injecting a dose of PGF2α and the insertion 
of a progesterone implant immediately after embryo recovery. Ten days later, the implant 
is removed and superovulation initiated following the next estrus with an average of 40 
days between superovulations. A disadvantage of superovulation programs is that the 
donor response to this treatment sometimes decreases after repeated applications (Seidel, 
1981; Donaldson and Perry, 1983). Several other factors influencing superovulatory 
treatments and embryo transfer were recently investigated by Stroud and Hasler (2006). 
In this review, the total number of ova/embryos recovered, the number of transferable 
embryos, and pregnancy rates after embryo transfer, were all positively correlated to 
good farm management (nutrition, recipient selection, synchronization protocols, estrous 
detection, and synchrony between donor and recipient) and semen evaluation before 
insemination of donor cows. Schrick et al. (2003) demonstrated a highly significant 
relationship between semen quality and the percentage of fertilized ova and transferable 
embryos in superovulated donors. Moreover, semen quality was also positively related to 
the percentage of excellent-quality embryos.  
Embryo mortality after natural mating or AI from day 24 to term is only between 
3 and 5% (Paisley et al., 1978; Sreenan and Diskin, 1986). These losses are in agreement 
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with data reported by King et al. (1985) who investigated losses associated to fresh 
embryo transfers. In this study, 3.15% and 2.14% pregnancies resulted in abortion 
between 2 and 3 months and 3 to 7 month of gestation, respectively. On the other hand, 
pregnancy rates from day 60 to term after transfer of frozen-thawed embryos resulted in 
abortion rates of 9.6 and 12.8% (Dochi et al., 1998). McMillan and Donnison (1999), in 
an attempt to understand maternal contributions to fertility in recipient cows, transferred 
in vitro-produced blastocyst stage embryo into contemporary beef heifers. After 
pregnancy diagnosis, pregnancies were terminated with a luteolytic dose of PGF2α and 
the process repeated 6 more times over a period of 26 months. Based on pregnancy data 
obtained at 60 days following each round of transfers, heifers were ranked as high and 
low fertility. Pregnancy rates for the High and Low sub-herds were 76% and 11%, 
respectively, with 55% and 37% of this differences due to losses before day 25 (return to 
estrous) and losses between day 25 and 35, respectively. Moreover, when other 
reproductive parameters related to fertility were evaluated (site of ovulation, incidence of 
standing estrus, interval to end of estrus to standing  estrus, and progesterone profiles 
during the estrous cycle), no differences between these two groups were observed, 
indicating no differences in fertility at the level of the ovary. The authors suggested that 
the mechanism of maternal recognition of pregnancy (MRP) is a major cause of 
differences between these two groups; however, losses during MRP were not observed. 
Dunne et al. (2000) reported that embryo loss following artificial insemination in beef 
heifers occurred by day 14 after mating with little loss after this time. 
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22. Implications of prostaglandin F2α release during embryo transfer in cows 
The bovine endometrium contains relatively large amounts of arachidonic acid 
that can be rapidly converted to different products such as PGF2α (Salamonsen and 
Findlay, 1990). In fact, manipulation of the reproductive tract during embryo transfer 
resulted in PGF2α release from the uterine endometrium (Scenna et al., 2005). Other 
studies have also reported a release of PGF2α following uterine manipulation in mares 
(Kask and Odensvik, 1995), sows (Kunavongkrit et al., 1984) and cows (Wann and 
Randel, 1990). On the other hand, Odensvik et al. (1993) did not report an increase in 
concentrations of plasma PGF2α after non-surgical embryo transfer in heifers. Differences 
among these studies may be attributed to differences in breed, handling of blood samples, 
and in the methodology used for determining PGF2α concentrations (indirect 
determination of PGF2α through measuring PGFM vs. direct determination).  
Manipulation of the reproductive tract causes uterine trauma followed by an 
inflammatory process with release of several chemical mediators such as cytokines and 
prostaglandins. One of the most important cytokines, tumor necrosis factor α (TNF-α), is 
capable of inducing PGF2α release by luteal cells (Nothnick and Pate, 1990) and epithelial 
cells in the uterine endometrium via activation of PLA2 and nitric oxide synthase 
(Skarzynski et al., 2000). Moreover, Okuda et al. (2002) suggested that endometrial TNF-
α may be a trigger for the production of PGF2α from the uterine endometrium during 
luteolysis. Since treatment of luteal cells with PGF2α induced further production of PGF2α 
by this cell type in sheep (Rexroad and Guthrie, 1979; Wade and Lewis, 1996) and pigs 
(Guthrie et al., 1979), PGF2α release after embryo transfer in cows may be able to 
stimulate its own production from the reproductive tract.  
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Even though release of PGF2α during embryo transfer may not result in luteolysis, 
embryonic survival may be compromised by the presence of small concentrations of 
PGF2α in the uterine lumen, creating a “hostile environment” for embryonic development. 
Scenna et al. (2004) demonstrated that development of in vitro-produced 16- to 32-cell 
embryos to blastocyst stage was reduced by addition of PGF2α in the culture media. In 
addition, culture of in vivo-derived compact morulae in medium containing PGF2α did not 
affect development to blastocyst, but reduced hatching rates (Scenna et al., 2004). This is 
in agreement with Maurer and Beier (1976) who reported that addition of PGF2α to 
culture media directly decreased the ability of 8-cell rabbit embryos to form expanded 
and hatched blastocysts, but had no effect on development to early blastocyst. Successful 
hatching of the embryo is thought to be a key event for further embryonic development 
and proper implantation in humans (Petersen et al., 2004). In fact, assisted hatching of 
human embryos (consisting in creating a complete or partial hole in the zona pellucida) 
has been shown to result in better implantation rate after embryo transfer in humans (Ali 
et al., 2003; Kung et al., 2003; Wong et al., 2003).  
Administration of flunixin meglumine (FM), an inhibitor of PGF2α synthesis, at 
the time of embryo transfer resulted in increased pregnancy rates at the time of embryo 
transfer (Scenna et al., 2005). The same study showed no differences on pregnancy rate 
of quality 1 embryos following administration of FM when compared to control 
recipients. However, transfer of quality 2 embryos to recipient animals receiving FM 
resulted in higher pregnancy rates than control animals, indicating that developmentally 
compromised embryos (quality 2) are most susceptible to deleterious effects of PGF2α 
than those of better quality (quality 1). 
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In agreement with these findings, Elli et al. (2001), McNaughtan et al. (2002), 
Pugh et al. (2004) and Purcell et al. (2004) reported beneficial effects of prostaglandin 
synthesis inhibitors on pregnancy rates in recipient cows after embryo transfer. In 
humans, women undergoing in vitro fertilization and receiving a daily oral dose of aspirin 
(an inhibitor of prostaglandin synthesis) had better ovarian responsiveness (greater 
number of follicles and oocytes retrieved), uterine and ovarian blood flow velocity, 
implantation, and pregnancy rates than women receiving placebo (Rubinstein et al., 
1999). Similarly, Waldenstrom et al. (2004) reported higher pregnancy rates in women 
undergoing IVF and receiving a daily dose of aspirin from the day of embryo transfer 
until pregnancy diagnosis when compared to women not receiving a treatment. 
In conclusion, PGF2α synthesis and release at the time of embryo transfer may 
result in reduced pregnancy rate of recipient cows by altering/inhibiting the normal 
process of hatching. Moreover, developmentally-compromised embryos (those of lower 
quality) may be more susceptible to the effects of PGF2α than good quality embryos. New 
therapeutic techniques aimed at inhibiting synthesis or binding of PGF2α  to its receptor in 
bovine embryos will likely improve reproduction in cattle, as well as in humans 
undergoing assisted reproduction programs.   
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CHAPTER 3 
RECEPTOR-MEDIATED EFFECTS OF PROSTAGLANDIN F2α ON 
BOVINE EMBRYOS 
 
1. Abstract 
Prostaglandin F2α has been shown to have detrimental effects on embryonic 
development, quality and hatching ability of embryos and pregnancy rates in cows. In 
recipient cattle, administration of flunixin meglumine (a cyclooxygenase-1 and -2 
inhibitor) at embryo transfer reduced detrimental effects associated with PGF2α actions on 
establishment of pregnancy. Information regarding the presence of prostaglandin F2α 
receptor (FPr) mRNA and protein in bovine embryos is absent in the literature. The 
objectives of the current study were 1) to identify the period of time where in vitro-
derived embryos are most susceptible to PGF2α and 2) to determine the presence of 
prostaglandin F2α receptor (FPr) mRNA and protein in bovine embryos. Results indicated 
that culture of pre-compacted embryos for 48 h in medium containing 1 ng/mL of PGF2α 
had decreased development to compact morula when compared to control embryos  (PGF 
1=55%C vs. CON=64%; P<0.05). On the other hand, culture of compacted embryos in 
medium containing 1 ng/mL of PGF2α did not decrease development to blastocyst (PGF 
1=57 vs. CON=59%). In addition, expression of FPr mRNA and protein in bovine 
embryos was confirmed by real time PCR and Western Blot analysis, respectively. In 
conclusion, PGF2α decreases embryonic development of bovine embryos to compact 
morula, but once compaction occurred, PGF2α does not appear to affect further 
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embryonic development in vitro. Furthermore, PGF2α can have a direct negative effect on 
development of bovine embryos by activating its own cell membrane receptor. 
 
2. Introduction 
Prostaglandins, also called prostanoids, are ubiquitously produced compounds 
that mediate many physiological processes, including many reproductive functions 
(reviewed by Weems and coworkers, (2006). Receptors for tromboxane A2 (TP), 
prostaglandin D2 (DP), prostaglandin E2 (EP1-4), prostaglandin I2 (IP), and prostaglandin 
F2α (FP), are integral membrane proteins that present seven transmembrane domains and 
are coupled to specific G proteins mediating the formation of second messengers such as 
cAMP, DAG and inositol triphosphate (Findlay et al., 1993; Hata and Breyer, 2004). The 
prostaglandin F2α receptor (FPr) has been cloned from bovine (Sakamoto et al., 1994), 
ovine (Graves et al., 1995), mice (Sugimoto et al., 1994), rat (Kitanaka et al., 1994) and 
human (Abramovitz et al., 1994) cDNA libraries. In addition, several isoforms of this 
receptor have been cloned from cDNA libraries of ovine and bovine corpus luteum 
(Sakamoto et al., 1994; Pierce et al., 1997; Ishii and Sakamoto, 2001; Sakamoto et al., 
2002).   
Embryonic losses in bovine appear to occur soon after the embryo enters the 
uterus (5 to 8 days after mating or insemination), when the morula stage embryo is 
transitioning to blastocyst (Ayalon, 1978; Maurer and Chenault, 1983; Wiebold, 1988; 
Dunne et al., 2000). Previous studies have shown a detrimental effect of PGF2α on in 
vitro development of rat, rabbit and bovine embryos (Maurer and Beier, 1976; Breuel et 
al., 1993; Scenna et al., 2004). Furthermore, administration of PGF2α on days 5 through 8 
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after artificial insemination or mating has also been shown to decrease embryonic 
development, quality and pregnancy rates in progesterone-supplemented cows (Buford et 
al., 1996; Hockett et al., 2004; Sales et al., 2004). In addition, administration of 
prostaglandin synthesis inhibitors increased pregnancy rates after transfer in cows (Elli et 
al., 2001; McNaughtan et al., 2002; Pugh et al., 2004; Purcell et al., 2004; Scenna et al., 
2005).  
The objectives of this study were 1) to identify the period of time during in vitro 
embryo development that embryos are most susceptible to detrimental effects of PGF2α, 
and 2) to determine the presence of FPr gene and protein expression in bovine embryos.  
 
3. Experimental procedures 
3.1 Materials  
Polyvinyl alcohol (PVA), bovine serum albumin (BSA), percoll, penicillamine, 
hypotaurine, epinephrine and the majority of reagents used for in vitro production of 
bovine embryos were purchased from Sigma Chemical, Inc. (St. Louis, MO).   Tissue 
culture medium-199, gentamicin, and penicillin-streptomycin were purchased from 
Specialty Media, Inc. (Phillipsburg, NJ). Fetal bovine serum (FBS) was obtained from 
BioWhittaker (Walkersville, MD). Folltropin-V and Vigro holding Plus were purchased 
from Bioniche Life Sciences, Inc. (Belleville, ON). Ovaries were purchased from a local 
abattoir. Media (HEPES-TALP, IVF-TALP, AND SPERM-TALP (Parrish et al., 1988)) 
and KSOM (Edwards et al., 2005), were prepared in the laboratory. Sperm characteristics 
(percent motile sperm and concentration) were analyzed using a computerized sperm 
analyzer (CASA; Hamilton Thorne Biosciences; Beverly, MA). The PicoPure RNA 
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isolation Kit was purchased from Arcturus (Mountain View, CA). DNase I enzyme and 
RNAlater were purchased from Ambion (Austin, TX). Trizol Reagent was obtained from 
Invitrogen (Carlsbad, CA). All reagents for the RT reaction (5X RT Buffer, 25 mM 
Magnesium Chloride, Random Primers, RNasin Ribonuclease Inhibitor, dNTP Mix, and 
M-MLV Reverse Transcriptase) were purchased from Promega (Madison, WI). iQTM 
SYBR Green Supermix was purchased from Bio-Rad (Hercules, CA).  
 
3.2. General procedures for in vitro production of bovine embryos 
The procedures utilized for in vitro production of embryos (IVP) were 
modifications of procedures previously described by Lawrence et al. (2004). Ovaries 
obtained from an abattoir were packaged in thermoses and contained within a cooler 
during air transport to the laboratory.  Upon arrival to the laboratory, ovaries were 
immediately washed with warm tap water equilibrated to arrival temperature of ovaries 
(generally between 28 to 30°C).  Excess tissue surrounding ovaries was removed with 
scissors and ovaries were washed with warm tap water an additional time.  
For oocyte recovery, ovaries were held firmly by clamping the base of the ovary 
with a hemostat and checkerboard incisions were made across follicles (approximately 3-
8 mm in diameter) using a scalpel blade. Ovaries were vigorously washed in oocyte 
collection medium (OCM) in order to remove cumulus oocyte complexes (COCs) 
contained within the follicles. Collection medium was filtered and rinsed using an Emcon 
Filter unit (Vet Concepts, Spring Valley, WI) until medium was clear. Medium 
containing COCs was poured into a gridded culture dish where searching of oocytes was 
accomplished. Cumulus oocyte complexes were transferred to an “X” plate containing 
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OCM and washed four times to eliminate cellular debris. Cumulus oocyte complexes of 
good quality (even cytoplasm, at least 3-4 layers of tight cumulus cells) were washed in 
oocyte maturation medium (OMM; M-199 with Earle’s salts, 10% fetal bovine serum, 50 
μg/mL gentamicin, 5 μg/mL LH, 0.2 mM sodium pyruvate, and 2 mM L-glutamine) and 
placed in groups of approximately 50 COCs per well in a 4-well plate containing 500 μL 
OMM. Maturation of oocytes was performed in an incubator at 5.5% CO2 in air at 38.5°C 
until time of fertilization (approximately 24 h after placement in OMM). Maturation 
medium was equilibrated in the incubator (5.5% CO2 in air at 38.5°C) the day before 
oocyte collection.   
 
3.2.1. Sperm preparation and in vitro fertilization 
 
 After oocyte maturation (22-24 h in OMM in an incubator at 5.5% CO2 in air at 
38.5°C), OMM from each well was carefully removed and 25 μL of 
penicillamine/hypotaurine/epinephrine (PHE) and 500 μL of fertilization medium (IVF-
TALP) were added to each well. Two straws of semen from two bulls (140 Se5, 140 
Se55, 30 SM002, CG30, SM 101), known to have high motility as well as producing high 
cleavage and blastocyst percentages were used to fertilize oocytes for every replicate of 
the study. Briefly, semen straws were removed from liquid nitrogen tank and placed in 
water at 36.7°C for 45 sec.  Each straw was then emptied on top of a discontinuous 
percoll density gradient (3 mL 45% percoll over 3 mL 90% percoll contained in a 15 mL 
conical tube) and sperm was centrifuged at 760 x g for 15 min in order to remove excess 
extender, debris, and nonmotile sperm prior to fertilization. Sperm pellet present at the 
bottom of the 90% fraction was collected and transferred to 10 mL SPERM-TALP and 
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centrifuged at 200 x g for 8 min. Supernatant was removed and sperm pellet re-suspended 
in 100 μL of modified IVF-TALP. Sperm concentration and motility were determined 
using a CASA and sperm was added to each well at a final concentration of 500,000 
motile sperm per well. Lastly, oocytes and sperm were incubated at 5.5% CO2 in air at 
38.5°C for 18-22 h. 
 
3.2.2. In vitro culture 
 
  Approximately 18-22 h post fertilization, putative zygotes (PZ) were denuded of 
cumulus cells by vortexing. Putative zygotes were transferred to a 2 mL centrifuge tube 
containing 50 μL of HEPES-TALP and vortexed for 5 min. Recovered putative zygotes 
were washed 4 times in HEPES-TALP before transferring groups of approximately 40-50 
zygotes to each well of a 4-well plate containing 500 μL of KSOM culture medium per 
well. Zygotes were placed in a humidified atmosphere of 5.5% CO2, 7% O2, and 87.5% 
N2 at 38.5°C until they were collected at 16-32 cells (approximately 97 h post IVF), 
compact morula (approximately 145 h post IVF) or blastocyst stage (approximately 193 h 
post IVF) to perform each experiment.  
 
3.3. Time-specific effects of PGF2α during in vitro embryo development  
Previous data in our laboratory have shown that addition of PGF2α to the culture 
medium of pre-compacted in vitro produced embryos (during days 4 to 9 of embryonic 
development) results in decreased embryonic development when compared to embryos 
cultured in control medium (Scenna et al., 2004). In order to investigate time-specific 
effects of PGF2α during in vitro embryo development, embryonic development of pre-
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compacted (Experiment 1) and compacted embryos (Experiment 2) cultured in medium 
containing PGF2α was compared to embryos cultured in control medium. 
 
 
3.3.1. Preparation of PGF2α stock and   treatment wells 
 
Prior to the beginning of each experiment, prostaglandin F2α (1 mg; Cayman 
Chemical Inc., Ann Arbor, MI, catalog#) was solubilized in 10 mL of DMSO (Stock #1 
100,000 ng/mL). Then, 30 μL aliquots were stored at -20C° until needed. For each 
replicate of the experiment, serial 10-fold dilutions of PGF2α stock #1 in KSOM-PVA 
(0.3%) were made to yield 1 ng/mL of PGF2α in KSOM-PVA culture medium. Control 
experimental wells were prepared by adding a DMSO (0.001%) concentration equal to 
the one use to prepare 1 ng/mL of PGF2α in KSOM-PVA. Four-well plates containing 
treatment wells (500 μl KSOM-PVA without the addition of PGF2α or with the addition 
of 1 ng/mL PGF2α) were equilibrated in an incubator (5.5% CO2, 7% O2, and 87.5% N2 at 
38.5°C) for at least 12 h before placing embryos in their respective treatments. Addition 
of 1 ng/mL PGF2α has been previously shown to result in lowered embryonic 
development of in vitro produced bovine embryos (Scenna et al., 2004). 
 
3.3.2. Experiment 1: Effects of PGF2α on pre-compacted embryos 
Procedures for oocyte collection, maturation, fertilization and embryo culture 
were previously described under general methods. Pre-compacted (16- to 32-cell stage; 
approximately at 97 h post IVF) embryos were rapidly transferred from KSOM culture 
medium to pre-warmed HEPES-TALP for evaluation. Embryos were evaluated for 
quality (normal shape, defined blastomeres, extruded blastomeres, cytoplasmic 
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fragmentation, even cytoplasm) and evenly sorted according to their quality. Embryos 
were rapidly washed at least twice in KSOM-PVA and transferred to their respective 
treatments in a 4-well plate. Experimental plates were placed in the incubator (5.5% CO2, 
7% O2, and 87.5% N2 at 38.5°C) for 2 additional days when embryo development to 
compact morula stage was determined using IETS guidelines for classification of bovine 
embryos (Stringfellow and Seidel, 1998). Data for development to compact morula were 
analyzed using a randomized block design model with replicate (a 4 well plate with each 
well containing a treatment and a group of embryos considered an experimental unit) as 
random effect and treatment as fixed effect performing mixed procedures of SAS 
software (SAS 9.1, SAS Institute Inc., Cary, NC).  
A total of 6 replicates were utilized to investigate the effects of PGF2α on pre 
compacted in vitro-derived embryos. In each of these replicates, pre-compacted embryos 
received one of the following treatments: 1) CON (KSOM-PVA; n= 183), or 2) PGF 1 (1 
ng/ml PGF2α in KSOM-PVA; n= 184).  
 
3.3.3. Experiment 2: Effects of PGF2α on compacted embryos 
Procedures for oocyte collection, maturation, fertilization and embryo culture 
were previously described under general methods. Compact morula stage embryos 
(collected at approximately 145 h post IVF) were rapidly transferred from KSOM culture 
medium to pre-warmed HEPES-TALP for evaluation. Embryos were evaluated for 
quality (normal shape, defined blastomeres, extruded blastomeres, cytoplasmic 
fragmentation, even cytoplasm) and evenly sorted according to their quality. Embryos 
were rapidly washed at least twice in KSOM-PVA and transferred to their respective 
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treatments in a 4-well plate. Experimental plates were placed in the incubator (5.5% CO2, 
7% O2, and 87.5% N2 at 38.5°C) for 2 additional days when embryo development to 
blastocyst stage was determined using IETS guidelines for classification of bovine 
embryos (Stringfellow and Seidel, 1998). Data for development to blastocyst were 
analyzed using a randomized block design model with replicate (a 4-well plate with each 
of its wells containing one treatment; a group of embryos in each well was considered an 
experimental unit) as random effect and treatment as fixed effect performing mixed 
procedures of SAS software (SAS 9.1, SAS Institute Inc., Cary, NC).  
A total of 11 replicates were utilized to investigate the effects of PGF2α on 
compacted in vitro-derived embryos. In each of these replicates, compact morula stage 
embryos received one of the following treatments: 1) CON (KSOM-PVA; n= 268), or 2) 
PGF 1 (1 ng/ml PGF2α in KSOM-PVA; n= 278). 
 
3.4. Determination of FPr mRNA and protein in bovine embryos 
3.4.1. Preparation of embryo and semen samples for reverse transcription-real time-PCR 
Due to a concern regarding the amplification of PGF2α transcripts associated with 
the accessory sperm present in the zona pellucida (ZP) of bovine embryo (Nadir et al., 
1993), PCR was performed in ZP-intact and ZP-free in vitro-derived compact morula and 
blastocyst stage embryos. Mechanical removal of ZPs from embryos was the preferred 
method over pronase treatment because it also allowed PCR analysis of isolated ZPs. 
Mechanical removal of ZPs was performed following procedures described by Edwards 
et al. (2003) to remove ZPs of bovine embryos. Briefly, embryos were removed from 
culture medium and washed 3 times in HEPES-TALP-PVA (0.3% PVA). Groups of 5 
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embryos were transferred to 10 μL drops of 0.3M sucrose (Van Soom et al., 1996) 
covered in mineral oil to induce shrinkage of the embryo mass. Following shrinkage of 
embryos, the majority of the 0.3 M sucrose solution was removed, and as a result, the 
weight of the mineral oil maintained embryos in place forming a tight group of embryos. 
Next, a 27-gauge tuberculin needle associated with its corresponding syringe was used to 
produce a hole in the ZP of each embryo. Each group of embryos was resuspended in 
HEPES-TALP-PVA and transferred to HEPES-TALP-PVA in a 4-well plate. Using a 
glass pipette just slightly thinner than the embryo’s size each embryo was liberated from 
the ZP by gently pipetting. Zona pellucida-intact, ZP-free embryos and their 
corresponding ZPs (in groups of 20-30 embryos or ZPs) were washed in HEPES-TALP-
PVA loaded in 2.5 μL of HEPES-TALP-PVA, lysed in 25 μL of RNA lysis buffer 
(Arcturus, Mountain View, CA) and stored at -80°C until use.  
Semen straws from the same bull (BN 354) utilized for in vitro production of 
embryos used for detection of FPr protein were removed from liquid nitrogen tank and 
placed in water at 36.7°C for 45 sec.  Straw were then emptied on top of a discontinuous 
percoll density gradient (3 mL 45% percoll over 3 mL 90% percoll contained in a 15 mL 
conical tube) and sperm centrifuged at 760 x g for 15 min. Sperm pellet present at the 
bottom of the 90% fraction was transferred to 10 mL HEPES-TALP-PVA column and 
centrifuged at 200 x g for 8 min. Supernatant was removed and sperm pellet re-suspended 
in 100 μL of modified IVF-TALP for determination of sperm motility and concentration. 
Approximately 2,500,500 sperm were then lysed in 50 µL of RNA lysis buffer and stored 
at -80°C until use. 
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3.4.2. Isolation of RNA 
Total RNA was isolated using the PicoPure RNA isolation Kit (Arcturus, 
Mountain View, CA) as per the manufacturer’s instructions. Briefly, RNA was mixed 
with 70% ethanol by gently pipetting and the mixture was added to an RNA purification 
column. DNAse treatment was performed by addition and incubation of DNase I enzyme 
(Qiagen, Valencia, CA) 15 min at room temperature in the RNA purification columns. 
Several washes of the columns were performed previous to elution of RNA from the 
column by using 12 μL elution buffer. 
As a positive control, total RNA from bovine tongue epithelium was isolated 
using Trizol Reagent (Invitrogen, Carlsbad, CA). Bovine tongue tissue was obtained from 
a fresh tongue in a local abattoir. Epithelial cells were obtained by slicing of bovine 
tongue epithelium in sections less than 0.5 mm thick. Collected tissue was immediately 
placed in RNA later (Qiagen, Valencia, CA). Tissue was left at 4°C overnight and kept at 
-80°C until use. To isolate RNA, 100 mg of tongue epithelium was placed in a 17 x 100 
mm polypropylene tube containing 1 mL of Trizol and homogenized with a Tekmar 
Tissumizer (Tekmar Co., Cincinnati, OH). Homogenized samples were incubated for 5 
min at room temperature and then mixed with 0.2 mL of chloroform. Tubes were 
vigorously shaken by hand for 15 sec and incubated at room temperature for 15 min. 
Samples were centrifuged at 12,000 x g for 10 min at 4°C. Next, the aqueous phase was 
transferred to a new tube, and in which RNA was precipitated by the addition of 0.5 mL 
isopropyl alcohol and incubation of the samples at room temperature for 15 min. Samples 
were centrifuged at 12,000 x g for 10 min at 4°C, the supernatant removed and the 
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resulting RNA pellet washed once using 75% ethanol. Lastly, the RNA pellet was air-
dried for 5 min, dissolved in 50 μL of nuclease free water and stored at -80°C until used.  
 
3.4.3. Reverse transcription 
Isolated RNA from bovine embryos and bovine tongue epithelium was DNAase 
treated and reversed transcribed into complementary DNA in a total volume of 20 μL. 
The reaction mixture consisted of 1X RT buffer, 5 mM MgCl2, 1 mM of each dNTP, 0.25 
nM random primers, 20 IU RNase inhibitor, and 100 IU moleney murine leukemia virus 
reverse transcriptase (MMLV-RT). The RT reaction was carried out at 25°C for 10 min, 
42°C for 1 h followed by a denaturation step at 99°C for 5 min and flash cooling to 4°C. 
Controls for genomic DNA contamination were prepared by omitting reverse 
transcriptase enzyme in the RT reaction.  
 
3.4.4. Real time PCR  
Polymerase chain reaction was performed using the iCycler iQTM Real-Time PCR 
detection system (Bio-Rad, Hercules, CA) and the iQTM SYBR Green Supermix (Bio-
Rad, Hercules, CA). The PCR reaction mixture consisted of 25 μL 1X iQ Supermix (100 
mM KCl, 40 mM Tris-HCl pH 8.4, 0.4 mM of each dNTP, iTaq DNA Polymerase 50 
units/ml, 6 mM MgCl2, SYBR Green I, 20 nM fluorescein, and stabilizers), 1 μM 
concentration of forward and reverse primers for FPr and β-actin (Table 1), nuclease free 
water, and cDNA template from each RT reaction. Negative control for each primer set 
consisted of PCR reaction mixture without the inclusion of cDNA (no template). 
Amplification of housekeeping gene actin (Rambeaud et al., 2006), were used as standard 
Table 1. Details of primers used for RT-RT-PCR. 
 
         
Gene 
GenBank 
Accesion 
Number 
 
Sense 
     
Sequence 
          
Location 
         
Fragment 
Size (bp) 
 
PGF2α 
receptor 
 
NM181025 
 
Forward 
 
5’-gcagaccaagcacagtgaaa-3’ 
5’-ctgacagccaaccacgtatg-3’ 
 
1487-1506 
1618-1637 
 
151 
 Reverse 
 
β-Actin 
 
 AY141970.1 
 
 
Forward 
Reverse 
 
5’-cggcattcacgaaactacct -3’ 
5’-gggcagtgatctctttctg-3’ 
  
855-875 
978-997 
 
143 
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positive controls for the PCR reaction. The Real Time PCR protocol included an initial 
step of 95°C for 15 min, followed by 40 cycles of 95°C for 15 sec, 55°C for 30 sec, and 
72°C for 30 sec. Fluorescence data was acquired during the elongation step. Since the 
melting curve of PCR products is sequence specific, it is used to identify PCR products. 
Melting protocol was performed by holding temperature at 45°C for 60 sec and then 
heating from 45 to 94°C, holding at each temperature for 5 sec while monitoring 
fluorescence. Product identity was also confirmed by ethidium-bromide-stained 2% 
agarose gel electrophoresis in 1X TBE (90 mM Tris, 90 mM borate, 2 mM EDTA, pH 
8.3) visualized using a gel doc apparatus (Bio-Rad, Hercules, CA) and by target 
sequencing (University of Tennessee Molecular Biology Core Facility). At least three 
replicates containing ZP-intact and ZP-free embryos were utilized in this experiment.  
 
3.4.5. Tissue collection for Western blot 
In vitro-derived embryos were sorted according to their developmental stage in 
compact morulae and blastocysts, whereas in vivo-derived (ethylene glycol or glycerol 
frozen-thawed embryos) embryos at compact morula and blastocyst stage were pooled 
together into one group. To avoid foreign protein contamination, embryos were washed at 
least 3 times in HEPES-TALP supplemented with 0.3% PVA instead of BSA. Embryos 
were lysed in 2% SDS Extraction Buffer as described by Morgan et al. (1993) with the 
addition of a protease inhibitor cocktail (Roche, Indianapolis, IN). Lysate was heated at 
94°C for 3 min and sonicated for 1 min. Lastly, samples were stored at -80°C until use.  
Tissue from corpus luteum (CL) was removed from ovaries obtained at a local 
abattoir. Tissue was cut in thin slices (less than 1 mm) with a scalpel blade and placed in 
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a 17x100 mm polypropylene tube (BD Biosciences, San Jose, CA). Extraction buffer 
with protease inhibitors was added to the tube and tissue homogenized in Tekmar’s 
Tissumizer for approximately for 5 min or until no gross debris were observed. 
Homogenate was centrifuged through a BD Falcon cell strainer (BD Biosciences 
Discovery Labware, Bedford, MA) attached to a 50 mL conicle tube for 2 min at 700 x g, 
aliquoted and stored at -80°C until use. 
 Two straws of frozen-thawed semen from two bulls (same bulls used for in vitro 
production of embryos)  were centrifuged at 760 x g for 15 min using a percoll density 
gradient (3 mL 45% percoll over 3 mL 90% percoll contained in a 15 mL conical tube). 
Sperm pellet at the bottom of the tube was transferred to 10 mL HEPES-TALP-PVA 
(0.3%) and centrifuged at 200 x g for 8 min. Supernatant was removed and sperm pellet 
re-suspended in 100 μL of HEPES-TALP-PVA (0.3%). A total of 100 μL from the sperm 
mixture was combined with 100 μL of extraction buffer, heated at 94°C for 5 min and 
stored at -80°C until use.  
 
3.4.6. Western blot 
Protein concentration from corpus luteum and embryos was determined using the 
NanoOrange Protein Quantitation Kit following the manufacturer’s instructions 
(Invitrogen, Carlsbad, CA) in a TBS-380 minifluorometer (Turner Biosystems, 
Sunnyvale, CA). Proteins in each sample were loaded and electrophoresed on a 12% SDS 
polyacrylamide gel using 1X SDS-Running Buffer (3.02 g Tris, 18.8 g Glycine, 10 ml 
10% SDS, Qs to 1 lt) at 20 mAmp/100 V for 2.5 h. Electrophoresed proteins were 
electroblotted onto a PVDF membrane (Bio-Rad, Hercules, CA)  using a semi dry 
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apparatus (Bio-Rad, Hercules, CA) at 12 constant volts for 25 min. Prestained SDS 
standards (Bio-Rad, Hercules, CA) and chemiluminescence standards (MagicMark XP 
Standards, Invitrogen, Carlsbad, CA) were loaded to confirm transfer to PVDF 
membrane and to serve as molecular weight standards when developing the western blot, 
respectively. As positive control, a crude protein extract from bovine corpus luteum was 
used to determine the presence of FPr protein. After electrotransfer, SDS gels were 
stained with 0.1% Coomassie Blue solution to evaluate protein transfer efficiency, 
whereas PVDF membranes were dried overnight at 4°C. Membranes were then re-
hydrated in 100% methanol for a few seconds, washed twice in water and blotted. 
Proteins were blocked for 1 h at room temperature with 10% non-fat dried milk (NFDM) 
in PBS. Blots were washed 3 times at 10 min intervals in PBS with 0.05% Tween-20 
(PBS-T). Blots were incubated with primary antibody (rabbit polyclonal IgG raised 
against mouse FP receptor, Cayman Chemical Inc, Ann Arbor, MI) for 1 h at room 
temperature at a dilution of 1:1000 in 2% NFDM in PBS and washed 3 times with PBS-
T. Blots were then incubated with secondary antibody (Goat anti-rabbit IgG, Pierce, 
Rockford, IL) for 1 h at room temperature at a dilution of 1:1000 in 1% NFDM in PBS 
and washed 3 times with PBS-T. Blots were developed using a chemiluminescence kit 
(SuperSignal West Femto Maximum Sensitivity Substrate, Pierce, Rockford, IL) 
following manufacturer’s instructions. In this study, at least 3 replicates of in vitro-
derived morulae, 3 replicates of in vitro-derived blastocysts, and 2 replicates of in vivo-
derived embryos were utilized to study FPr protein expression in bovine embryos. 
 
 
4. Results 
4.1. Time-specific effects of PGF2α during in vitro embryo development 
Incubation of pre-compacted embryos with 1 ng/ml of PGF2α in the culture 
medium decreased the percentage of embryos reaching compaction 48 h later (PGF 1=55 
± 7.7 vs. CON=64 ± 7.7%; P<0.05; Figure 2). Whereas, culture of compacted embryos in 
medium containing 1 ng/ml of PGF2α did not result in lowered blastocyst formation (PGF 
1=57 ± 7.3% vs. CON=59 ± 7.3%; P>0.05; Figure 2).    
 
4.2. FPr gene 
Prostaglandin F2α receptor transcripts were successfully amplified from ZP-intact 
and ZP-free compact morula and blastocyst stage bovine embryos (Figure 3 and 4), as 
well as from tongue epithelium (the positive control; Figure 4) and bovine sperm (Figure 
4). In contrast, transcripts for FPr were not observed in mechanically removed ZPs. In 
addition, amplification of the housekeeping gene β-actin was observed in all samples 
including mechanically removed ZPs. DNA contamination was not evident as negative 
controls did not result in any of the genes used being amplified (no template and RT 
negative reactions; Figure 3 and 4).  Amplification products were positively identified by 
melting curve profiles and ethidium-bromide gel electrophoresis (Figure 3 and 4).  
 
4.3. FPr protein expression 
Because gene expression does not always correlate with protein expression, 
western blots were performed on in vitro and in vivo-derived embryos. Western blot 
analysis confirmed the expression of FPr protein in in vitro-derived blastocysts stage  
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Figure 2. Embryonic development of pre-compacted (Experiment 1) and compacted 
(Experiment 2) embryos after 48 h culture in medium containing 1 ng/ml of 
prostaglandin F2α or in control medium. Embryonic development of pre-compacted, but 
not compacted embryos was inhibited by addition of prostaglandin F2α to the culture 
medium. a.bValues differ within treatments (P<0.05). Pooled standard errors were ± 7.7. 
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 β-actin ZP-Free Compact Morula
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FPr ZP-Free Compact Morula
FPr ZP-Free Blastocysts
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Figure 3. Real time RT PCR using SYBR Green I. A) Amplification curves for 
prostaglandin F2α receptor (FPr) and β-actin transcripts in ZP-free and ZP-intact 
blastocysts and ZP-free compact morulae. Each embryo sample was used for 
amplification of FPr and β-actin transcripts; therefore each line represents an embryo 
sample. Controls for genomic DNA contamination for each of these embryo samples 
(omission of reverse transcriptase enzyme) showed no FPr amplification. B) 
Amplification products were positively identified by melting curve profile. Three 
replicates for ZP-intact and 3 replicates for ZP-free embryos at compact morula or 
blastocyst stage were utilized for determination of FPr transcripts in in vitro-derived 
embryos. 
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Figure 4. Ethidium bromide gel electrophoresis: Lane 1: PCR markers; lane 2: FPr in 
tongue epithelium (positive control); lane 3: FPr no template (negative control); lane 4: β-
actin in tongue epithelium; lane 5: β-actin no template (negative control); lane 6: FPr in 
ZP-free blastocysts; lane 7:  β-actin in ZP-free blastocysts; lane 8: FPr with RT negative 
reaction ZP-free blastocyst; lane 9: FPr in ZP-intact blastocyst; lane 10:  β-actin in ZP-
intact blastocyst; lane 11: FPr with RT negative reaction from ZP-intact blastocyst; lane 
12: FPr in ZP-free compact morulae; lane 13: β-actin in ZP-free compact morulae; lane 
14: FPr in RT negative from ZP-free compact morulae; lane 15: FPr in mechanically 
isolated zona pellucidas; lane 16: β-actin in mechanically isolated zona pellucidas; lane 
17: FPr in RT negative from mechanically isolated zona pellucidas. 
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embryos, in vivo-derived (compact morulae and blastocysts) embryos, sperm, and corpus 
luteum samples (Figure 5). In addition, FPr was identified as approximately a 64 kDa 
protein. Pre-absorption of the primary antibody with its corresponding blocking peptide 
resulted in negative western blots which confirmed the specificity of the primary 
antibody to the FPr. Detection of FPr in in vitro-derived compact morulae was not 
evident.  
 
5. Discussion 
Several studies have indicated a negative effect of PGF2α on embryonic 
development, hatching ability and embryo quality in different species (Maurer and 
Chenault, 1983; Breuel et al., 1993; Buford et al., 1996; Lemaster et al., 1999; Hockett et 
al., 2004). Moreover, Scenna et al., (2004) indicated that culture of pre-compacted in 
vitro-derived bovine embryos in medium containing PGF2α decreased development to 
blastocyst. In the later study, time specific effects of PGF2α on pre-compacted or 
compacted in vitro-derived embryos could not be determined because pre-compacted 
embryos were treated with PGF2α until assessment of development to blastocyst. The 
objective of our initial experiment was to identify the period of time where in vitro-
derived embryos are most susceptible to detrimental effects of PGF2α. In this study, 
addition of PGF2α to the culture medium of pre-compacted bovine embryos reduced the 
ability of the embryos to undergo compaction. To the contrary, addition of PGF2α to the 
culture medium of compacted embryos did not cause a reduction in blastocyst formation.  
In a second experiment, the hypothesis that PGF2α has a direct negative effect on 
embryos was strengthened by identification of FPr mRNA in ZP-free compact morula 
  
Sperm CL
ZP intact
In vivo
ZP intact
In vitro
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Western blot for FPr protein in bovine sperm, bovine corpus luteum (CL), zona 
pellucida (ZP) intact in vivo-derived bovine embryos, and zona pellucida (ZP) intact in 
vitro-derived bovine embryos. 
 73
 74
and blastocyst stage embryos. Mechanical removal of the embryo from the zona pellucida 
was performed to avoid PCR amplification of PGF2α transcripts associated with accessory 
sperm present in the zona pellucida (ZP) of the embryo (Nadir et al., 1993). In addition, 
Western blot analysis indicated that in vitro-derived blastocysts and in vivo-derived 
(compact morulae and blastocysts) bovine embryos, semen samples, and corpus luteum 
(used as positive control) expressed FPr protein.  
It is important to mention that amplification of FPr and β-actin transcripts were 
observed in bovine sperm samples. Furthermore, β-actin transcripts, but not FPr 
transcripts were amplified from mechanically isolated ZPs. These results suggest that 
amplification of β-actin transcripts from ZPs are a consequence of amplification of 
transcripts from accessory sperm present in the ZPs of in vitro-derived embryos. Lack of 
FPr mRNA from ZP samples may be explained by a lower amount of FPr transcripts 
compared to β-actin transcripts (a housekeeping gene) in the accessory sperm associated 
with ZP. The presence of mRNA in sperm was also correlated with the presence of FPr 
protein by Western blot. 
Prostaglandin F2α receptor protein expression in in vitro-derived compact morulae 
was not detectable; therefore, FPr gene expression did not correlate with its protein 
expression in in vitro-derived compact morulae. The fact that we did not detect FPr 
protein expression in compact morulae does not rule out the possibility that pre-
compacted and compacted embryos express small amounts of FPr that under our 
experimental conditions were unable to be detected, but were sufficient enough to cause 
an effect of PGF2α on the embryo. In addition, due to the lipophilic characteristics of 
prostaglandins (Bito, 1975) and the presence of prostaglandin transporters mediating 
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influx and efflux of prostaglandins to cells (Lu et al., 1996; Chan et al., 1998), negative 
effects of PGF2α in pre-compacted embryos may also occur via none receptor-mediated 
events. This hypothesis agrees with a study performed by Scenna et al. (2004) in which 
culture of pre-compacted bovine embryos in medium containing 1, 10 or 100 ng/ml of 
PGF2α decreased development to blastocyst; however, 1 ng/mL of PGF2α had a more 
detrimental effect than addition of 10 ng/mL (Scenna et al., 2004), suggesting that effects 
of PGF2α did not involve a receptor-mediated event. Therefore, non receptor-mediated 
effects of PGF2α on the embryo may explain in part the negative effects of PGF2α on in 
vitro development of pre-compacted embryos observed in our initial experiment.  
Moreover, lack of PGF2α effects on development of compact morulae to 
blastocyst stage suggests that once the embryo compacts, PGF2α effects on the embryo 
ceases. However, due to the fact that previous studies have indicated a reduction on 
hatching rates of compacted bovine embryos with PGF2α (Scenna et al., 2004) and that 
only a very low number of in vitro-derived embryos usually hatch from the zona 
pellucida, negative effects of PGF2α on hatching may still be possible.  
Until now, two isoforms for the FPr protein have been identified in ruminants; the 
original FP isoform named FPA and a newer isoform generated by alternative mRNA 
splicing named FPB (Pierce et al., 1997; Iwamoto et al., 1999). The molecular weight of 
FPr protein presented in this study was approximately 64 kDA, which agrees with several 
other studies showing expression of a 64 kDA FPr protein in bovine ocular tissues 
(Ansari et al., 2004; Kaddour-Djebbar et al., 2005; Thieme et al., 2006). However, the 
FPr molecular weight reported in our study differs from other studies in humans 
(Abramovitz et al., 1994) and bovines (Sakamoto et al., 1995) after cloning of FPr in 
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those species. The aforementioned studies estimated a molecular weight of 40,060 and 
40,983 Daltons for the human and bovine FPr, respectively. In agreement with these 
authors, Al-Matubsi et al. (2001) demonstrated the presence of a 43 kDa FPr in rat 
myometrium by Western blotting.  
In conclusion, our results indicated that direct effects of PGF2α on in vitro-derived 
embryos occur before or during compaction, but the possibility of PGF2α affecting 
hatching of blastocyst from the zona pellucida still remains. In addition, to our 
knowledge, we have demonstrated for the first time the existence of FPr mRNA (in in 
vitro-derived compact morulae and blastocyst) and protein (in in vitro-derived blastocysts 
and in vivo-derived pools of morulae and blastocysts) in bovine embryos. These findings 
suggest that PGF2α can have a direct negative effect on development of bovine embryos 
by receptor and non receptor-mediated events.   
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CHAPTER 4 
DETRIMENTAL EFFECTS OF PROSTAGLANDIN F2α ON IN 
VITRO EMBRYO DEVELOPMENT IN BOVINE ARE INHIBITED 
BY A RECEPTOR ANTAGONIST 
 
1. Abstract 
Numerous studies have demonstrated negative effects of prostaglandin F2α 
(PGF2α) on bovine reproduction. Moreover, previous data from our laboratory indicated 
that in vitro-derived pre-compacted embryos are more susceptible to the effects of PGF2α 
than compacted embryos. Presence of prostaglandin F2α receptors (FPr) in bovine 
embryos will allow for new therapeutic strategies aimed at improving reproduction in 
bovines. Therefore, in Experiment 1, two studies were performed to investigate any toxic 
or negative effect of AL-8810, an FPr antagonist, on in vitro development of bovine 
embryos. In this study, pre-compacted embryos were culture in: 1) 25 AL (25 nM AL-
8810 in KSOM-PVA; n= 94); 2) 50 AL (50 nM AL-8810 in KSOM-PVA; n= 94); 3) 100 
AL (100 nM AL-8810 in KSOM-PVA; n= 94); and 4) CON (KSOM-PVA; n= 95). 
Subsequently, pre-compacted embryos were cultured in: 1) 250 AL (250 nM AL-8810 in 
KSOM-PVA; n=274); 2) 500 AL (500 nM AL-8810 in KSOM-PVA; n=274); 3) 1000 
AL (1000 nM AL-8810 in KSOM-PVA; n= 282); and 4) CON (KSOM-PVA; n= 278). In 
Experiment 1, embryos remained in their treatments until blastocyst assessment. Next, in 
Experiment 2, the efficacy of AL-8810 on preventing detrimental effects of PGF2α on 
pre-compacted embryos was investigated. In this experiment, pre-compacted embryos 
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were cultured in: 1) 100 AL (100 nM AL-8810 in KSOM-PVA; n= 121); 2) 10 PGF (10 
ng/mL of PGF2α in KSOM-PVA; n=91); 3) 100 AL + PGF (100 nM AL-8810 and 10 
ng/mL of PGF2α in KSOM-PVA; n=116); and 4) CON (KSOM-PVA; n= 96). 
Subsequently, pre-compacted embryos were cultured in: 1) 1000 AL (1000 nM AL-8810 
in KSOM-PVA; n= 87); 2) 10 PGF (10 ng/mL of PGF2α in KSOM-PVA; n=87); 3) 1000 
AL + PGF (1000 nM AL-8810 and 10 ng/mL of PGF2α in KSOM-PVA; n=84); and 4) 
CON (KSOM-PVA; n= 84). In Experiment 2, embryos remained in their treatments for 
approximately 48 h when development to morula was assessed. Results showed that 
addition of 25, 50, 100 nM did not compromise embryonic development to blastocyst 
compared to controls (61%, 56%, 55%, and 50% respectively). In addition, orthogonal 
contrasts indicated that 100 nM AL-8810 improved development to blastocyst (100 AL= 
61% vs. CON= 50%, P=0.01). Culture of embryos with 250, 500, 1000 nM AL-8810 did 
not affect development to blastocyst (35%, 39% and 40%, respectively) when compared 
to controls (38%). Finally, addition of 1000 nM AL-8810, but not 100 nM, to culture 
medium of pre-compacted embryos exposed to PGF2α increased the ability of embryos to 
undergo compaction 48 h later (1000 AL + PGF=51% vs. PGF=40%; P=0.05). In 
conclusion, AL-8810 at a concentration of 1000 nM inhibits detrimental effects of PGF2α 
on development of pre-compacted bovine embryos and may prove beneficial for other 
assisted reproductive techniques in cattle.    
 
2. Introduction 
Inadequate reproductive efficiency has a tremendous impact in the economy of 
dairy and beef producers. Moreover, early embryonic death in cattle represents 75 to 80% 
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of all reproductive losses between fertilization and calving (Sreenan and Diskin, 1983). 
Prostaglandin F2α (PGF2α), a derivate of arachidonic acid (Flint et al., 1986) and the 
primary luteolytic hormone in ruminants (Goding, 1974; Braden et al., 1988; Okuda et 
al., 2002) has been shown to decrease embryo quality and development and to lower 
pregnancy rates in cows (Seals et al., 1998; Lemaster et al., 1999; Elli et al., 2001; 
McNaughtan et al., 2002; Pugh et al., 2004; Purcell et al., 2004; Scenna et al., 2005). In 
addition, PGF2α decrease embryonic development of rabbit, rat and bovine embryos in 
vitro (Maurer and Beier, 1976; Breuel et al., 1993; Scenna et al., 2004).  
The FPr is a seven transmembrane protein receptor coupled to a specific G protein 
(Gq) mediating the formation of inositol triphospate (IP3) and diacylglycerol (DAG), 
second messengers (Coleman et al., 1994) leading to an increase in intracellular calcium 
levels and activation of protein kinase C (Wiltbank et al., 1989; Wiltbank et al., 1989; 
Wiltbank et al., 1990). Downstream signaling are not well understood, but an 
involvement of a Raf/MEK/MAPK signaling cascade followed by regulation of gene 
transcription has been suggested by Chen et al. (1998). Moreover, several isoforms of the 
FPr receptor have been characterized in bovine and ovine luteal cells (Ezashi et al., 1997; 
Pierce et al., 1997; Ishii and Sakamoto, 2001; Sakamoto et al., 2002). A selective 
antagonist for the FPr, AL-8810, has been well characterized by Griffin et al. (1999). 
This antagonist has been shown to inhibit calcium mobilization and MAP kinase 
activation induced after stimulation with several PGF2α agonists (Sharif et al., 2001; 
Kelly et al., 2003; Sharif et al., 2003).  
Recent studies from our laboratory have demonstrated the presence of 
prostaglandin F2α receptor (FPr) mRNA and protein in bovine embryos (Scenna et al. 
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2006). Presence of FPr in bovine embryos allows for the development of new therapeutic 
strategies to improve embryo quality, development and survival in cows, which will 
result in better reproductive efficiency and higher monetary earnings to the cattle 
industry. Therefore, the objectives of this study were to 1) determine if AL-8810 
possesses any toxic effect for in vitro culture of bovine embryos, and 2) to inhibit 
detrimental effects of PGF2α on in vitro development of bovine embryos. 
 
3. Experimental procedures 
 
3.1. Materials 
Dimethyl sulphoxide (DMSO), polyvinyl alcohol (PVA), bovine serum albumin 
(BSA), percoll, penicillamine, hypotaurine, epinephrine and the majority of reagents used 
for in vitro production of bovine embryos were purchased from Sigma Chemical, Inc. (St. 
Louis, MO).   Tissue culture medium-199, gentamicin, and penicillin-streptomycin were 
purchased from Specialty Media, Inc. (Phillipsburg, NJ). Fetal bovine serum (FBS) was 
obtained from BioWhittaker (Walkersville, MD). Folltropin-V and Vigro holding Plus 
were purchased from Bioniche Life Sciences, Inc. (Belleville, ON). Ovaries were 
purchased from Brown’s Packing Plant (Gaffney, SC). Media (HEPES-TALP, IVF-
TALP, and SPERM-TALP; Parrish et al., 1988) and KSOM (Edwards et al., 2005), were 
prepared in the laboratory. Sperm characteristics were analyzed using a computerized 
sperm analyzer (CASA) from Hamilton Thorne Biosciences (Beverly, MA). 
 
 
 
 81
3.2. General procedures for in vitro production of bovine embryos 
3.2.1. Oocyte collection 
The procedures utilized for in vitro production of embryos (IVP) were 
modifications of procedures previously described by Lawrence et al. (2004). Ovaries 
obtained from an abattoir were packaged in thermoses and contained within a cooler 
during air transport to the laboratory.  Upon arrival to the laboratory, ovaries were 
immediately washed with warm tap water equilibrated to arrival temperature of ovaries 
(generally between 28 to 30 C°).  Excess of tissue surrounding ovaries was removed 
utilizing a scissor and ovaries were washed with warm tap water an additional time.  
For oocyte recovery, ovaries were held firmly by clamping the base of the ovary 
with a hemostat and checkerboard incisions were made across follicles (approximately 3-
8 mm in diameter) using a scalpel blade. Ovaries were vigorously washed in oocyte 
collection medium (OCM) in order to remove cumulus oocyte complexes (COCs) 
contained within the follicles. Collection medium was filtered and rinsed using an Emcon 
Filter unit (Vet Concepts, Spring Valley, WI) until medium was clear. Medium 
containing COCs was poured into a gridded culture dish where searching of oocytes was 
accomplished. Cumulus oocyte complexes were transferred to an “X” plate containing 
OCM and washed four times to eliminate cellular debris. Cumulus oocyte complexes of 
good quality were washed in oocyte maturation medium (OMM) and placed in groups of 
approximately 50 COCs per well in a 4-well plate containing 500 μL OMM. Maturation 
of oocytes was performed in an incubator at 5.5% CO2 in air at 38.5° C until time of 
fertilization (approximately 24 h after placement in OMM). Maturation medium was 
equilibrated in the incubator (5.5% CO2 in air at 38.5°C) the day before oocyte collection.   
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3.2.2. Sperm preparation and in vitro fertilization 
 
 After oocyte maturation (22-24 h in OMM in an incubator at 5.5% CO2 in air at 
38.5°C), OMM from each well was carefully removed and 25 μl of 
penicillamine/hypotaurine/epinephrine (PHE) and 500 μL of fertilization medium (IVF-
TALP) were added to each well. Two straws of semen from two bulls (140 Se5, 140 
Se55, 30 SM002, CG30, SM 101), known to have high motility as well as producing high 
cleavage and blastocyst percentages were used to fertilize oocytes for every replicate of 
the study. Briefly, semen straws were removed from liquid nitrogen tank and placed in 
water at 36.7°C for 45 sec.  Each straw was then emptied on top of a discontinuous 
Percoll density gradient (3 mL 45% percoll over 3 mL 90% percoll contained in a 15 mL 
conical tube) and sperm was centrifuged at 760 g for 15 min in order to remove excess 
extender, debris, and nonmotile sperm prior to fertilization. Sperm pellet present at the 
bottom of the 90% fraction was collected and transferred to 10 mL SPERM-TALP and 
centrifuged at 200 g for 8 min. Supernatant was removed and sperm pellet re-suspended 
in 100 μL of modified IVF-TALP. Sperm concentration and motility were determined 
using a CASA and sperm was added to each well at a final concentration of 500,000 
motile sperm per well. Lastly, oocytes and sperm were incubated at 5.5% CO2 in air at 
38.5°C for 18-22 h. 
 
 
3.2.3 In vitro culture 
 
  Approximately 18-22 h post fertilization, putative zygotes (PZ) were denuded of 
cumulus cells by vortexing. Putative zygotes were transferred to a 2 mL centrifuge tube 
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containing 50 μL of HEPES-TALP and vortexed for 5 min. Recovered putative zygotes 
were washed 4 times in HEPES-TALP before transferring groups of approximately 40-50 
zygotes to each well of a 4-well plate containing 500 μL of KSOM culture medium per 
well. Zygotes were placed in a humidified atmosphere of 5.5% CO2, 7% O2, and 87.5% 
N2 at 38.5°C until desired stage of development and initiation of respective treatments. 
 
 3.3. Experiment 1: Determination of AL-8810 dose toxicity on in vitro embryo 
development  
AL-8810 is an 11β-fluoro analog of PGF2α which acts as a potent and selective 
antagonist at the FP receptor. This compound has weak intrinsic activity on FPr in the 
200-300 nM range. However, it fully antagonizes the activity of the potent FPr agonist 
fluprostenol at these concentrations (Griffin et al., 1999). At a concentration of 1 to 2 μM, 
AL-8810 inhibits several potent agonists at the cloned human ciliary body (Sharif et al., 
2002). In addition, AL-8810 does not inhibit the activity of prostaglandin E, D, I 
receptors (Crider et al., 1998; Crider et al., 1998; Crider et al., 1999) suggesting a 
selective antagonism at the FP receptor.  
The effects of AL-8810 during in vitro embryo development in cattle have not 
been studied. Therefore, two preliminary experiments were performed to determine 
possible negative effects (or toxicity) of AL-8810 on embryonic development of in vitro-
produced embryos cultured in KSOM-PVA (3 mg/mL, 0.3%) alone or in KSM-PVA with 
the addition of 6 different concentrations of AL-8810.  
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3.3.1. Preparation of AL-8810 stock and addition to the culture medium 
Prior to the beginning of each experiment, the content of a vial containing 10 mg 
of AL-8810 (Cayman Chemical Inc., Ann Arbor, MI; catalog# 16735) was reconstituted 
and solubilized in DMSO (Primary Stock, 1000 μM AL-8810). Aliquots of 1 ml of 
primary stock solution were stored at -80C° until needed. For each replicate, the primary 
stock solution was diluted 1:10 in KSOM-PVA (Secondary Stock, 100 μM AL-8810) and 
added to each experimental well (500 μl of equilibrated KSOM-PVA) to obtain final 
concentrations of 25, 50, 100, 250, 500, and 1000 nM AL-8810. Control experimental 
wells were prepared by adding the same concentration of DMSO (0.1%) used to prepare 
the highest concentration of AL-8810 in KSOM-PVA. 
 
3.3.2. Experimental design for Experiment 1 
Procedures for oocyte collection, maturation, fertilization and embryo culture 
were previously described under general methods. Pre-compacted 16- to 32-cell stage 
embryos (approximately 97 h post IVF) were rapidly transferred to HEPES-TALP, 
evaluated for quality (normal shape, defined blastomeres, extruded blastomeres, 
cytoplasmic fragmentation, even cytoplasm), evenly sorted according to their quality, 
washed rapidly in KSOM-PVA, and transferred to experimental treatments in a 4-well 
plate. Experimental plates were placed in the incubator (5.5% CO2, 7% O2, and 87.5% N2 
at 38.5°C) for 3 additional days when embryo development was determined using IETS 
guidelines for classification of bovine embryos (Stringfellow and Seidel, 1998). Data for 
development to blastocyst were analyzed using a randomized block design model with 
replicate (a 4-well plate with each of its wells containing one treatment; a group of 
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embryos in each well was considered an experimental unit) as random effect and 
treatment as fixed effect performing mixed procedures of SAS software (SAS 9.1, SAS 
Institute Inc., Cary, NC). In addition, orthogonal contrasts were performed to determine 
differences on development to blastocyst among treatments. 
A total of 5 replicates were utilized to investigate the effects of 25, 50, 100, and 0 
nM of AL-8810 on in vitro embryo development. In each of these replicates, pre-
compacted embryos at 16- to 32-cell stage received one of the following culture 
treatments: 1) 25 AL (25 nM AL-8810 in KSOM-PVA; n= 94); 2) 50 AL (50 nM AL-
8810 in KSOM-PVA; n= 94); 3) 100 AL (100 nM AL-8810 in KSOM-PVA; n= 94); and 
4) 0 CON (KSOM-PVA; n= 95; Figure 6). 
A total of 11 replicates were used to investigate the effects of 250, 500, 1000, and 
0 nM of AL-8810 on in vitro embryo development. In each of these replicates, pre-
compacted embryos at 16- to 32-cell stage received one of the following culture 
treatments: 1) 250 AL (250 nM AL-8810 in KSOM-PVA; n=274); 2) 500 AL (500 nM 
AL-8810 in KSOM-PVA; n=274); 3) 1000 AL (1000 nM AL-8810 in KSOM-PVA; n= 
282); 0 CON (KSOM-PVA; n= 278; Figure 7).  
 
3.4. Experiment 2: Does AL-8810 prevent detrimental effects of PGF2α on in vitro 
produced embryos? 
3.4.1 Preparation of prostaglandin F2α stocks 
Prior to the beginning of each experiment, prostaglandin F2α (1 mg; Cayman 
Chemical Inc., Ann Arbor, MI; catalog# 16010) was solubilized in 10 mL of DMSO each 
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Figure 6. Experimental design for determination of 25, 50, and 100 nM AL-8810 toxicity 
on in vitro embryo development of bovine embryos. Treatments were 25 nM AL-8810 
(25 AL), 50 nM AL-8810 (50 AL), 100 nM AL-8810 (100 AL), and Control. 
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Figure 7. Experimental design for determination of 250, 500, and 1000 nM AL-8810 
toxicity on in vitro embryo development of bovine embryos. Treatments were 250 nM 
AL-8810 (250 AL), 500 nM AL-8810 (500 AL), 1000 nM AL-8810 (1000 AL), and 
Control.  
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(Stock #1; 100,000 ng/mL). Then, 30 µL aliquots were stored at -80C° until needed. 
Based on manufacturer’s instructions, once PGF2α has been reconstituted in DMSO, the 
storage life of PGF2α at -80°C is 6 months. For each replicate of the experiment, 12.5 µL 
of PGF2α stock #1 were combined with 987.5 µL of KSOM-PVA (stock #2; 1.25 ng of 
PGF2α per µL). Next, 4 µL of stock #1 were added to each experimental well (500 µL of 
equilibrated KSOM-PVA or 500 μl of 100 nM AL-8810) to obtain a final concentration 
of 10 ng/mL of PGF2α in the culture medium. It is important to mention that PGF2α was 
added at least 30 min after the embryos were placed in 100 nM or 1000 nM AL-8810 to 
allow the interaction of the FPr antagonist with its receptors at the plasma membrane. 
Four-well plates containing 500 µL of KSOM-PVA in each well were equilibrated in an 
incubator (5.5% CO2, 7% O2, and 87.5% N2 at 38.5°C) for at least 12 h before initiation 
of treatments.  
 
3.4.2. Experimental design for Experiment 2  
Previous data from our laboratory demonstrated that addition of PGF2α to the 
culture medium of pre-compacted in vitro produced embryos reduced the ability of 
embryos to undergo compaction. On the other hand, exposure of compacted in vitro 
produced embryos to PGF2α did not compromise the ability of embryos to reach 
blastocyst stage (Scenna et al., 2006). Therefore, two experiments were performed to 
determine the ability of AL-8810 on preventing detrimental effects of PGF2α on in vitro 
produced pre-compacted embryos. 
Procedures for oocyte collection, maturation, fertilization and embryo culture 
were previously described under general methods. Embryos at the 16- to 32-cell were 
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rapidly transferred to HEPES-TALP, evaluated for quality (normal shape, defined 
blastomeres, extruded blastomeres, cytoplasmic fragmentation, even cytoplasm), evenly 
sorted according to their quality, washed rapidly in KSOM-PVA, and transferred to 
experimental treatments in a 4-well plate.  
A total of 5 replicates were used to evaluate effects of 100 nM AL-8810 on 
embryonic development of embryos cultured in medium containing PGF2α. Pre-
compacted embryos at 16- to 32-cell embryos received one of the following culture 
treatments: 1) 100 AL (100 nM AL-8810 in KSOM-PVA; n= 121); 2) PGF-10 (10 ng/mL 
of PGF2α in KSOM-PVA; n=91); 3) 100 AL + PGF-10 (100 nM AL-8810 and 10 ng/mL 
of PGF2α in KSOM-PVA; n=116); 4) CON (KSOM-PVA; n= 96; Figure 8). 
Subsequently, a total of 3 replicates were performed to determine the effects of 1000 nM 
AL-8810 on embryonic development of pre-compacted embryos exposed to PGF2α. In 
this study, 16-32-cell embryos were cultured in: 1) 1000 AL (1000 nM AL-8810 in 
KSOM-PVA; n= 87); 3) PGF-10 (10 ng/mL of PGF2α in KSOM-PVA; n=87); 3) 1000 
AL + PGF-10 (1000 nM AL-8810 and 10 ng/mL of PGF2α in KSOM-PVA; n=84); 4)  
CON (KSOM-PVA; n= 84; Figure 9). It is important to mention that PGF2α was added at 
least 30 min after the embryos were placed in 1000 nM AL-8810 to allow the interaction 
of the FPr antagonist with its receptors at the plasma membrane. 
In each of these two experiments, experimental plates were placed in the 
incubator (5.5% CO2, 7% O2, and 87.5% N2 at 38.5°C) for 48 h and embryo development 
to compact morula was determined using IETS guidelines for classification of bovine 
embryos. Collected data were analyzed by using mixed procedures of SAS software 
(SAS 9.1, Cary, NC). Data for development to compact morula were analyzed using a 
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Figure 8. Experimental design for evaluation of AL-8810 efficacy on inhibiting 
prostaglandin F2α effects on pre-compacted bovine embryos. Treatments were 100 nM 
AL-8810 (100 AL), 10 ng/mL prostaglandin F2α (PGF-10), 100 nM AL-8810 + 10 ng/mL 
prostaglandin F2α, (100 AL + PGF-10) and control.  
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Figure 9. Experimental design for evaluation of AL-8810 efficacy on inhibiting 
prostaglandin F2α effects on pre-compacted bovine embryos. Treatments were 1000 nM 
AL-8810 (1000 AL), 10 ng/mL prostaglandin F2α (PGF-10), 1000 nM AL-8810 + 10 
ng/mL prostaglandin F2α (1000 AL + PGF-10) and control. 
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randomized block design model with replicate (a 4-well plate with each of its wells 
containing one treatment; a group of embryos in each well was considered an 
experimental unit) as random effect and treatment as fixed effect performing mixed 
procedures of SAS software (SAS 9.1, SAS Institute Inc., Cary, NC). In addition, 
orthogonal contrasts were performed to determine differences on development to 
compact morula stage among treatments. 
 
4. Results 
Data from Experiment 1 indicated that culture of pre-compacted in vitro produced 
embryos in medium containing 25, 50, and 100 nM of the specific FPr antagonist AL-
8810, did not have a negative (or toxic) effect on embryonic development when 
compared to embryos cultured in control medium (61%, 56 %, 55%, and 50%, 
respectively; Figure 10). Moreover, addition of AL-8810 at a concentration of 100 nM to 
the culture medium increased blastocyst formation when compared to control medium 
(61% vs. 50%, respectively, P=0.01). Similarly, addition of AL-8810 to the culture 
medium at a concentration of 250, 500, and 1000 nM did not cause any detrimental 
effects on the ability of embryos to reach blastocyst stage when compared to embryos 
cultured in control medium (40%, 39%, 35% and 38%, respectively, Figure 11).  
In Experiment 2, no differences in embryonic development of pre-compacted 
embryos to morula stage between 100 AL, PGF-10, 100 AL+PGF and CON groups were 
observed (55%, 44%, 55%, and 51%; respectively; Figure 12). In addition, orthogonal 
contrast showed a strong tendency of 100 AL + PGF-10 and 100 AL to increase 
development to compact morula when compared to embryos treated with PGF2α (55% for 
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Figure 10. Percentage of pre-compacted embryos that continued development to 
blastocyst in Experiment 1 after culture in medium containing 25, 50, 100 nM AL-8810 
or control medium. a,b Values with different superscripts differ; P<0.005. Standard errors 
were ±  5.2 100 nM AL-8810, 25 nM AL-8810 and control, and ± 5.34 for 50 nM AL-
8810. 
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Figure 11. Percentage of pre-compacted embryos that continued development to 
blastocyst in Experiment 1 after culture in medium containing 250, 500, 1000 nM AL-
8810 or control medium. Standard errors were ±  3.63 for each treatment. 
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Figure 12. Percentage of pre compacted embryos that continued development to compact 
morula in Experiment 2. Treatments in Experiment 2a included: 100 nM AL-8810 (100 
AL), 10 ng/mL prostaglandin F2α (PGF-10), 100 nM AL-8810 + 10 ng/mL prostaglandin 
F2α (100 AL + PGF-10), and control (Con). Treatments in Experiment 2b were:  1000 nM 
AL-8810 (1000 AL), 10 ng/mL prostaglandin F2α (PGF-10), 1000 nM AL-8810 + 10 
ng/mL prostaglandin F2α (1000 AL + PGF-10), and control (Con). a,bValues differ 
between treatments; P=0.05. Standard errors in Experiment 2a were ± 4.8, 4.8, 4.8, and 
5.3 for 100 AL, PGF-10, 100 AL + PGF-10, and Con, respectively. Standard errors in 
Experiment 2b were ± 4.6, 4.6, 5, and 4.6 for 1000 AL, PGF-10, 1000 AL + PGF-10 and 
Con, respectively. 
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both treatments vs. 44% in PGF-10). In Experiment 2, no differences on development to 
morula stage were observed between 1000 AL, 1000 AL+PGF and CON (51%, 51% and 
52%, respectively; P>0.05; Figure 12). However, previous exposure of embryos to AL-
8810 before addition of PGF2α to the treatment well improved embryonic development to 
compact morula (1000 AL+PGF=51% vs. PGF=40%; P<0.05; Figure 12).  
 
5. Discussion 
Experiments 1 indicated that addition of various concentrations of an FPr 
antagonist, AL-8810, to the culture medium of in vitro-produced embryos did not result 
in lowered embryonic development. Furthermore, AL-8810 at a concentration of 100 nM 
in the culture medium improved the percentage of pre-compacted embryos reaching 
blastocyst stage. Since our culture system consisted in modified KSOM medium without 
the addition of animal proteins (bovine serum albumin), the positive effects of 100 nM of 
AL-8810 on embryonic development when compared to control medium was relatively 
unexpected. Several studies have indicated that embryos from different species are able 
to synthesize a wide range of prostaglandins (Shemesh et al., 1979; Hyland et al., 1982; 
Stone et al., 1986; Harper et al., 1989; Sayre and Lewis, 1993). Even though the presence 
of cyclooxygenase-1 (COX-1) cyclooxygenase-2 (COX-2) enzymes in bovine embryos 
has not been determined, studies in other species indicated that early stage embryos 
express these enzymes and are able to produce prostaglandins. For example, human 
embryos at early stage of development predominantly express COX-1, whereas 8-cell to 
blastocyst stage embryos express mostly COX-2 (Wang et al., 2002). Similarly, Parr et al. 
(1988) and Tan et al. (2005) demonstrated the presence of COX-1 and COX-2 in rat and 
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mouse embryos, respectively. In vitro-produced bovine embryos may be able to secrete 
discrete amounts of PGF2α to the culture medium, which in turn could have a negative 
effect on embryonic development. This may explain in part the beneficial effects 
observed on embryonic development after culturing embryos in medium containing 100 
nM of AL-8810 when compared to control medium.  
In Experiment 2, previous exposure of pre-compacted embryos to the FPr 
antagonist AL-8810 at a concentration of 1000 nM in the culture medium inhibited 
detrimental effects of PGF2α on embryonic development to morula stage. Similarly, 
several in vitro studies showed the efficacy and inhibitory actions of AL-8810 on 
inhibiting PGF2α effects after binding to its receptors. For example, previous exposure of 
mouse fibroblast to AL-8810 abolished the production of IP3 associated with FPr 
stimulation by FPr agonist (fluprostenol) or its endogenous ligand (PGF2α) (1999). 
Furthermore, several other studies also demonstrated the efficacy of AL-8810 on 
inhibiting the activation of FPr by several PGF2α agonists (Sharif et al., 2002; Kelly et al., 
2003; Sharif et al., 2003; Sharif et al., 2003).  
To date, the mechanism/s of action of PGF2α on bovine embryos has/have not 
been documented in the literature. However, based on the recent discovery of FPr in 
bovine embryos (Scenna et al., 2006), we can hypothesize that downstream signaling 
events occurring after PGF2α binds to its receptor are interfering with several mechanisms 
leading to compaction of bovine embryos. Compaction represents a key critical event for 
continued embryonic development. During this process, formation of junctional apical 
complexes (formed by E-cadherin and tight junctions) between outer blastomeres allows 
polarization and differentiation of these blastomeres into trophectoderm cells. On the 
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other hand, lack of junctional complexes and polarization of inner blastomeres allows 
these blastomeres to differentiate into the inner cell mass (Fleming et al., 2001). The 
junctional complexes between trophectoderm cells facilitate fluid accumulation within 
the blastocoele cavity and directly contributes to the formation of the blastocyst and its 
subsequent hatching from the zona pellucida (Watson et al., 1992; Fleming et al., 2001).  
It is tempting to hypothesize that PGF2α may impair the ability of pre-compacted 
embryos to undergo compaction by disassembling, destructing, or decreasing synthesis of 
cell-cell adhesion molecules (E-cadherin and tight junctions) between blastomeres. 
Indeed, studies have indicated that overexpression of COX-2 and therefore, an increase in 
prostaglandin synthesis, were associated with a disruption of cell-cell adhesion 
molecules, tumor formation, tumor invasion and metastasis (Hida et al., 1998; Takahashi 
et al., 2002). On the other hand, treatment of cancer cell lines with COX-2 specific 
inhibitors resulted in increased E-cadherin expression and inhibition of cell growth (Noda 
et al., 2002; Erdogru et al., 2005; Dohadwala et al., 2006).  In addition, upregulation of 
intracellular Ca++ (an effect associated with PGF2α actions on target cells) leads to 
contraction of Ca++  calmodulin-dependent actin-myosin filaments which in turn alters 
cellular shape, opens up TJ’s and increases paracellular permeability (Lindmark et al., 
1998). Moreover, protein kinase C (a protein activated by PGF2α on target cells) and the 
protein kinase C activator phorbol 12-myristate 13-acetate (PMA) have been shown to 
increase cellular permeability by opening of tight junctions (Sjo et al., 2003; Angelow et 
al., 2005). Furthermore, it has been shown that PGF2α stimulates the synthesis of matrix 
metalloproteinases (MMP’s; (Lindsey et al., 1996; Weinreb et al., 1997) which can in 
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turn induce proteolytic degradation of tight junction proteins and result in increase 
epithelial permeability (Wachtel et al., 1999; Lohmann et al., 2004; Gurney et al., 2006).  
Alterations in E-cadherin or tight junctions caused by the effects of PGF2α on the 
embryo may result in an impairment of the embryo to compact and form a blastocoele 
cavity, two critical steps for continued development. In fact, homozygous null mutants 
mouse embryos for the E-cadherin gene initially compacted (an event attributed to the 
presence of maternal or oogenetic E-cadherin proteins) but then proceeded to decompact, 
with cells becoming apolar due to interference in the formation of apical junctional 
complexes (Laure et al., 1994; Riethmacher et al., 1995). Moreover, these embryos failed 
to develop a normal blastocoel cavity and did not hatch from the zona pellucida 
(Riethmacher et al., 1995). Further evidence of the importance of E-cadherin on 
compaction was observed when mouse blastomeres decompacted after treatment with 
antibodies against Ca++-dependent molecules (Reima, 1990). Recently, targeted 
disruption of the E-cadherin gene in bovine pre-attachment embryos by RNA interference 
technology resulted in less embryos reaching compact morula or blastocyst stage 
(Nganvongpanit et al., 2006). These findings indicate a critical role of E-cadherin not 
only during compaction, but on further embryonic development in bovine embryos.  
In conclusion, addition of a selective FPr antagonist, AL-8810, to the culture 
medium of in vitro produced embryos inhibited detrimental effects of PGF2α on embryo 
development without toxicity. These findings suggest that the effects of PGF2α on bovine 
embryos are in part caused by receptor-mediated events and downstream signaling 
cascades. We hypothesized that binding of PGF2α to its receptor causes downstream 
signaling events (mobilization of intracellular Ca++, activation of PKC and MAPK’s) that 
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may decrease the embryos’ ability to compact by causing disruption, destruction or 
inhibition of synthesis of adherens and tight junctions between blastomeres. Moreover, 
addition of AL-8810 to the culture medium may become a standard procedure for 
enhancing development of in vitro produced mammalian embryos.  
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CHAPTER 5 
PREGNANCY RATES OF RECIPIENT ANIMALS FOLLOWING 
APPLICATION OF A SELECTIVE PROSTAGLANDIN F2Α 
RECEPTOR ANTAGONIST DURING EMBRYO RECOVERY 
 
1. Abstract 
In the presence of supplemental progesterone, prostaglandin F2α (PGF2α) has been 
shown to directly reduce embryo quality, development and pregnancy rates in cattle. The 
aim of this study was to evaluate addition of a PGF2α receptor (FPr) antagonist to 
collection medium on pregnancy rates after transfer of embryos to recipient animals. An 
initial experiment was performed to determine embryonic development and gene 
expression of in vivo-derived frozen-thawed embryos cultured in KSOM-PVA medium 
with 1000 nM AL-8810 (AL, n= 94), 1000 nM AL-8810 and 10 ng/mL PGF2α (AL+PGF, 
n= 94), 10 ng/mL PGF2α (PGF, n= 94), or serving as controls (CON, n= 91). Embryos 
remained in their treatment for a 30-h period, at the end of which embryo development 
per treatment was recorded. Embryos from each treatment group were then processed for 
analysis of Na+/K+ ATPase α1 and ZO-1 transcripts by reverse transcription real time 
PCR. In the subsequent study, embryos were recovered from superovulated donor cows 
on day 7 after artificial insemination with medium containing 1000 nM AL-8810 (Flush-
AL) or without (Flush-Con). Following collection in their respective treatment, embryos 
were classified by stage and quality and maintained in holding medium with 1000 nM 
AL-8810 or without until freezing, then transferred following thawing to suitable 
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recipients. Results from the initial experiment indicated that culture of in vivo-derived 
bovine embryos in medium containing AL-8810 improved blastocyst development 
compared to PGF (58% vs. 46%; P=0.05). In addition, a strong tendency on embryo 
development was observed in AL+PGF compared to PGF treatment group (57% vs. 46%; 
P=0.07). Blastocyst development of embryos in CON did not differ when compared to 
embryos in PGF (55% vs. 46%; P=0.12). Relative abundance of Na+/K+  ATPase α1 and 
ZO-1 transcripts among treatments did not differ. Recovery of embryos with medium 
containing AL-8810 increased pregnancy rates following embryo transfer when 
compared to embryos recovered without AL-8810 (Flush-AL= 46% ± 0.06 vs. Flush-
Con= 36% ± 0.06; P=0.04). In conclusion, the addition of an FPr antagonist prevented 
detrimental effects of PGF2α on in vitro development of in vivo-derived bovine embryos. 
Moreover, recovery of embryos with flushing medium containing an FPr antagonist 
improved pregnancy rates after transfer of embryos to recipient cows.  
 
2. Introduction 
Multiple ovulation and embryo transfer (MOET) programs in livestock 
production are utilized as a means for rapid acquisition of superior genetics and to 
increase productive life of elite donor cows by increasing the number of valuable 
progeny. Currently, MOET programs in cattle are used around the world, with more than 
500,000 embryos being transferred annually (Thibier, 2000). Efficiency of such programs 
in cattle depends on several factors associated with donor’s response to superovulation 
(Seidel, 1984), number of viable embryos recovered per collection (Donaldson and Perry, 
1983; Hasler et al., 1983; Seidel, 1984; Stroud and Hasler, 2006), and the percentage of 
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recipient animals establishing a pregnancy after transfer (Leibo, 1986; Hasler, 1992; 
Nibart and Humblot, 1997; Lester and McNew, 1999; Hasler, 2001, 2003). 
Manipulation of the reproductive tract during embryo transfer results in PGF2α 
release from the uterine endometrium (Scenna et al., 2005). Other studies have also 
reported a release of PGF2α following uterine manipulation in mares (Kask and Odensvik, 
1995), sows (Kunavongkrit et al., 1984) and cows (Wann and Randel, 1990). Moreover, 
several studies have shown detrimental effects of elevated PGF2α on in vitro development 
of rat, rabbit and bovine embryos (Maurer and Beier, 1976; Breuel et al., 1993; Scenna et 
al., 2004). Elevated PGF2α has also been shown to have detrimental effects on embryonic 
development, quality and hatching ability of embryos and pregnancy rates in cows, even 
in the presence of supplemental progesterone (Schrick et al., 1993; Buford et al., 1996; 
Lemaster et al., 1999; Elli et al., 2001; Hockett et al., 2004; Sales et al., 2004). 
Furthermore, administration of inhibitors of PGF2α synthesis at the time of embryo 
transfer to recipient animals increased pregnancy rates (Elli et al., 2001; McNaughtan et 
al., 2002; Pugh et al., 2004; Purcell et al., 2004; Scenna et al., 2005). 
The objectives of this study were 1) to determine in vitro development and gene 
expression of two relevant genes involved in blastocyst formation (Na+/K+ ATPase α1 
and ZO-1) of in vivo-derived bovine embryos cultured with a selective FPr antagonist; 
and 2) to determine if addition of a FPr antagonist to collection medium during recovery 
of bovine embryos increased pregnancy rates following transfer of these embryos to 
recipient cows. Improving pregnancy rates after embryo transfer in cows using an FPr 
antagonist will allow for development of new therapeutic techniques in other species, 
including humans, to increase reproduction and success rates. 
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3. Materials and Methods 
3.1. Experimental procedures to determine the effects of PGF2α and AL-8810 on 
development and relative abundance of genes associated with compaction  
3.1.1. Preparation of treatments 
 
3.1.1.1. Preparation of AL-8810  
 
Prior to the beginning of each experiment, the content of a vial containing 10 mg 
of AL-8810 (Cayman Chemical Inc., Ann Arbor, MI; catalog# 16735) was reconstituted 
and solubilized in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO; Primary 
Stock, 1000 μM AL-8810) to obtain a primary Stock solution of 1000 μM AL-8810. 
Aliquots containing 1 mL of primary stock solution were stored at -80°C until needed. 
For each replicate, the primary stock solution was diluted 1:10 in KSOM-PVA (0.3%; 
Secondary Stock, 100 μM AL-8810) and added to the experimental wells (495 μl of 
equilibrated KSOM-PVA) to obtain a final concentration of 1000 nM AL-8810 in the 
culture medium.  Control experimental wells were prepared by adding the same 
concentration of DMSO (0.1%) used to prepare AL-8810 in KSOM-PVA. 
 
3.1.1.2 Preparation of prostaglandin F2α 
Prior to the beginning of each experiment, prostaglandin F2α (5 mg; Cayman 
Chemical Inc., Ann Arbor, MI; catalog# 16010) was solubilized in 1 mL of DMSO each 
(Stock #1; 5,000 μg/mL). Then, 20 µL aliquots were stored at -80°C until needed. For 
each replicate of the experiment, 10 µL of PGF2α stock #1 were combined with 990 µL of 
KSOM-PVA (stock #2: 50 μg/mL). Next, 10 µL of stock #2 were combined with 490 μL 
of KSOM-PVA (stock #3: 1 μg/mL or 1 ng/μL). Finally, 5 μL of stock#3 were added to 
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each experimental well (495 µL of equilibrated KSOM-PVA) to obtain a final 
concentration of 10 ng/mL of PGF2α in the culture medium. Four-well plates with 
KSOM-PVA in each well were equilibrated in an incubator (5.5% CO2, 7% O2, and 
87.5% N2 at 38.5°C) for at least 12 h before preparation of treatments. 
 
3.1.2. Assignment of treatments 
In vivo-derived bovine embryos were thawed and sorted by stage of development 
and quality according to the IETS guidelines for classification of bovine embryos 
(Stringfellow and Seidel, 1998). Similar groups of embryos at the morula and early 
blastocyst stage of quality grade 1, 2 or 3 were washed three times in HEPES-TALP-
PVA (0.3%) and once in KSOM-PVA (0.3%) and randomly transferred to one of four 
treatments: 1) 1000 AL (1000 nM AL-8810 in KSOM-PVA, n=94); 2) 1000 AL + PGF-
10 (1000 nM AL-8810 + 10 ng/mL PGF2α in KSOM-PVA, n=94); 3) PGF-10 (10 ng/mL 
PGF2α in KSOM-PVA, n=94); and 4) CON (KSOM-PVA, n= 91; Figure 1) in a 4-well 
plate and placed in the incubator (5.5% CO2, 7% O2, and 87.5% N2 at 38.5°C). Three 
replicates were utilized for this experiment. It is important to mention that PGF2α was 
added at least 30 min after the embryos were placed in 1000 nM AL-8810 to allow the 
interaction of the FPr antagonist with its receptors before addition of PGF2α. 
After culturing embryos for 30 h, embryos from each treatment were placed in 
HEPES-TALP-PVA (0.1%) and development to blastocyst stage was recorded. Next, 
each treatment group (approximately 30 embryos) was washed 3 times in HEPES-TALP-
PVA (0.1%), loaded in 2.5 μL of HEPES-TALP-PVA (0.1%) and transferred to 25 μL of 
RNA lysis buffer (Arcturus, Mountain View, CA) and stored at -80° C until use. 
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3.1.3. Isolation of RNA 
Total RNA from each treatment group was isolated using the PicoPure RNA 
isolation Kit (Arcturus, Mountain View, CA) as per the manufacturer’s instructions. 
Briefly, RNA was mixed with 70% ethanol by gently pipetting and the mixture was 
added to an RNA purification column. DNAse treatment was performed by addition and 
incubation of DNase I enzyme (Qiagen, Valencia, CA) for 15 min at room temperature in 
the RNA purification columns. Several washes of the columns were performed previous 
to elution of RNA from the column by using 12 μL elution buffer. 
 
3.1.4. Reverse transcription  
Isolated RNA from bovine embryos and bovine tongue epithelium was reversed 
transcribed into complementary DNA in a total volume of 20 μL. The reaction mixture 
consisted of 1X RT buffer, 5 mM MgCl2, 1 mM of each dNTP, 0.25 nM random primers, 
20 iu RNase inhibitor, and 100 IU moleney murine leukaemia virus reverse transcriptase 
(MMLV-RT). The RT reaction was carried out at 25°C for 10 min, 42°C for 1 h followed 
by a denaturation step at 99°C for 5 min and flash cooling to 4°C. Controls for genomic 
DNA contamination were prepared by emitting reverse transcriptase enzyme in the RT 
reaction.  
 
3.1.5. Real time PCR  
Polymerase chain reaction was performed using the iCycler iQTM Real-Time PCR 
detection system (Bio-Rad, Hercules, CA) and the iQTM SYBR Green Supermix (Bio-
Rad, Hercules, CA). The PCR reaction mixture consisted of 25 μL 1X iQ Supermix (100 
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mM KCl, 40 mM Tris-HCl pH 8.4, 0.4 mM of each dNTP, iTaq DNA Polymerase 50 
units/ml, 6 mM MgCl2, SYBR Green I, 20 nM fluorescein, and stabilizers), 1 μM 
concentration of forward and reverse primers (Table 2) for β-actin (Rambeaud et al., 
2006), Na+/K+ ATPase α1 (Wrenzycki et al., 2003), and ZO-1, nuclease free water, and 
cDNA template from each RT reaction. Negative control for each embryo sample 
consisted of PCR amplification of RT negative reactions or mix without cDNA (no 
template). The real time PCR protocol included an initial step of 95°C for 15 min, 
followed by 40 cycles of 95°C for 15 sec, 55°C for 30 sec, and 72°C for 30 sec. 
Fluorescence data was acquired during the elongation step. Since the melting curve of 
PCR products is sequence specific, it is used to identify PCR products. Melting protocol 
was performed by holding temperature at 45°C for 60 sec and then heating from 45 to 
94°C, holding at each temperature for 10 sec while monitoring fluorescence. Product 
identity was also confirmed by ethidium-bromide-stained 2% agarose gel electrophoresis 
in 1X TBE (90 mM Tris, 90 mM borate, 2 mM EDTA, pH 8.3) visualized using a gel doc 
apparatus (Bio-Rad, Hercules, CA) and by target sequencing (University of Tennessee 
Molecular Biology Core Facility).  
 
3.1.6. Statistical analysis 
Collected data for ZO-1, and Na+/K+ ATPase α1 gene expression in each 
treatment were computed using the 2-∆∆Ct method described by Livak and Schmittgen 
(2001) and expressed as fold change in gene expression relative to control embryos 
samples after normalizing for β-actin gene expression. Data for mRNA expression and  
Table 2. Details of primers used for RT-RT-PCR. 
             
Gene 
GenBank 
Accesion 
Number 
    Sequence           
Location 
         
Fragment 
size (bp) 
NM_012504 Na+/K+ 
ATPase α1 
5’-acctgttgggcatccgagagac-3’ 
5’-agggaaggcacagaaccacca-3’ 
2882–2903 
3196–3217 
 
336 
ZO-1 L14837 5’-gtctgccattacacggtcct-3’ 
5’-ggcttaaatccaggggagtc-3’ 
3803-3822 
3921-3940 
138 
β-Actin AY141970.1 
 
5’-cggcattcacgaaactacct -3’ 855-875 
5’-gggcagtgatctctttctg-3’ 978-997 
143 
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development to blastocyst from a total of 3 replicates were analyzed using a randomized 
block design model with replicate (a 4-well plate with each of its wells containing one 
treatment; a group of embryos in each well was considered an experimental unit) as 
random effect and treatment as fixed effect performing mixed procedures of SAS 
software (SAS 9.1, SAS Institute Inc., Cary, NC). In addition, orthogonal contrasts were 
performed to determine differences on development to blastocyst among treatments. 
 
3.2. In vivo production of embryos 
3.2.1. Preparation of AL-8810  
 
AL-8810 (Cayman Chemical Inc., Ann Arbor, MI; 10 mg) was reconstituted and 
solubilized in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO; Primary Stock, 
1000 μM AL-8810) and aliquots containing 1 mL of primary stock solution were stored 
at -80°C until needed. For each liter of flushing medium, 1 mL of primary stock solution 
was added to obtain a final AL-8810 concentration of 1000 nM (Flush-AL1000). 
Similarly, 1 mL of DMSO was added to each liter of flushing medium (Flush-Con) to 
obtain the same amount of diluent (0.1%) as in the treatment flushing medium. In 
addition, an aliquot containing 1 mL of a ten fold dilution of the primary stock solution in 
DMSO was added to each liter of flushing medium to obtain a final AL-8810 
concentration of 100 nM (Flush-AL100). 
 
3.2.2. Estrous cycle synchronization and superovulation 
On day 5 after CIDR insertion (day 1; Eazi-Breed CIDR; Pfizer Animal Health, 
Kalamazoo, MI), embryo donors started a superovulation program consisting of 
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administration of pFSH (range of 162-400 mg i.m.; Folltropin-V, Bioniche, Belleville, 
Ontario, Canada) in decreasing doses twice daily for 4 days. Luteolysis was induced by 
administration of two doses of prostaglandin F2α (500 μg cloprostenol; Estrumate, 
Schering-Plough, Kenilworth, NJ; 12 h before and at the time of CIDR removal, day 9). 
Cows were fitted with Heatwatch® detectors (DDX, Boulder, CO) for estrous detection in 
addition to visual surveillance twice daily for 30 min. Cows were artificially inseminated 
with 1 unit of frozen-thawed semen at 12 h after standing estrus and again 12 h later.  
 
3.2.3. Embryo recovery and freezing 
Collection of embryos from donor cows (Angus breed) was performed 7 days 
after detection of estrus by placing a silicone catheter (Bioniche, Belleville, Ontario, 
Canada) through the cervix and up to the uterus body (Drost et al., 1976). The uterus was 
flushed several times with Vigro Complete Flush Solution (Bioniche, Belleville, Ontario, 
Canada), containing either 100 nM AL-8810 (Flush-AL100), 1000 nM AL-8810 (Flush-
AL1000) or dimethyl sulfoxide (DMSO; Flush-Con). Collected flush medium was 
filtered through a 0.22 μm EM-Con filter (Veterinary Concepts Incorporated, Spring 
Valley, WI) and searched for the presence of embryos. Embryos collected with Flush-
AL100, Flush-AL1000 or Flush-Con were placed into holding medium (Vigro Holding 
Plus; Bioniche, Belleville, Ontario, Canada) with either100 nM AL-8810, 1000 nM AL-
8810 or DMSO, respectively, and scored for quality and stage accordingly to the 
International Embryo Transfer Society guidelines (Stringfellow and Seidel, 1998). 
Following a 3X wash procedure in holding medium, embryos were frozen using 1.5 M 
ethylene glycol (Vigro Ethylene Glycol Freeze Plus; Bioniche, Belleville, Ontario, 
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Canada). Briefly, after scoring for stage and quality, embryos were placed for 5 min in 
1.5 M ethylene glycol. Embryos were then individually loaded into 0.25 mL straw and 
placed at -6°C in an automatic freezing unit (CL 5500; Cryologic, Mulgrave, Victoria, 
Australia). The freezing program consisted in holding embryos at -6°C for 10 min 
(seeding induced after 2 min at -6°C) followed by a descending freezing curve of 
0.5°C/min until reaching -32°C. Embryos remained at -32°C for 10 min and then were 
plunged into liquid nitrogen for final storage. Statistical analysis did not show differences 
in pregnancy rates following transfer between Flush-AL100 and Flush-AL1000; 
therefore, both treatment groups were combined as Flush-AL. 
 
3.2.4. Embryo transfer 
A total of 619 transfers into recipient cows (Registered Angus and Commercial 
[Angus X British, Continental, or Bos Indicus]) were performed in a two year period 
from February to May at four different locations in three states (Arkansas, Tennessee, 
and Texas). Recipients were in moderate body condition, multiparous, and provided ad 
libitum access to minerals, water and supplemental feed. Due to donor X semen 
interactions determined after transfer (Schrick & Saxton, unpublished data), only 425 
recipients were used for statistical analysis. Transfer data were included from the May 
2006 Arkansas study in which recipients were improperly vaccinated with a modified-
live vaccine during synchronization. Even though pregnancy rates were reduced in all 
animals across treatments for this replicate, the trend in pregnancy rates was similar to all 
other locations and thus, data were included in the final analyses. Animals that responded 
to estrus synchronization and had an acceptable corpus luteum were used as embryo 
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recipients 7 days (range 6-7.5 days) after detection of estrous. Briefly, animals were 
restrained in a cattle handling facility and location of the corpus luteum was determined 
by palpation per rectum or ultrasonography (Aloka 500 ultrasound unit equipped with a 
7.5MHz linear transducer; Corometrics Medical System, Wallingford, CT). Prior to 
embryo transfer, animals received an epidural injection of 2% lidocaine (2.5 ml; Lidoject; 
Burns Veterinary Supply, Inc., Westbury, NY) and the perineal region was washed with 
povidone solution. Embryos were thawed and non-surgically transferred to the upper 
third of the uterine horn ipsilateral to the CL (Schrick et al., 1993). Pregnancy rates were 
determined 30 to 60 days following transfer by ultrasonography or by palpation per 
rectum. 
 
3.2.5. Statistical analysis 
Data were arranged in a randomized block design. Pregnancy rates (%), embryo 
quality and stage variables were evaluated. Data pertaining to pregnancy rates were 
analyzed using generalized linear mixed models (Proc Glimmix; SAS version 9.1, 2003; 
SAS Institute Inc., Cary, NC). Data are presented as least squares means (± SEM). A 
model procedure that included flush treatment (Flush-AL or Flush-Con), quality (1 or 2), 
and stage (morula or blastocyst) were used to compare differences among treatments. 
Due to a possible direct effect on pregnancy rates, embryo quality and stage were used as 
covariates and location was included as a random effect. Differences in individual least 
squares means were protected by using Tukey-Kramer method. A P value less or equal to 
0.05 was considered statistically significant.  
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4. Results 
Results from the initial experiment indicated that culture of in vivo-derived bovine 
embryos in medium containing AL-8810 improved blastocyst development when 
compared to PGF (58% vs. 46%, respectively; P=0.05; Figure 13). In addition, a strong 
tendency on improving embryo development was observed in embryos cultured in 1000 
AL + PGF-10 compared to those cultured in PGF-10 (57% vs. 46%, respectively; 
P=0.07; Figure 13). Blastocyst development of embryos cultured in CON tended to be 
lower when compared to embryos in PGF-10 (55% vs. 46%, respectively; P=0.12; Figure 
13). Relative abundance of Na+/K+ ATPase α1 (Figure 14) and ZO-1 (Figure 15) 
transcripts did not differ between treatments. Moreover, pregnancy rates after transfer of 
embryos recovered with medium containing AL-8810 were higher than those obtained 
after transfer of embryos recovered with flushing medium without AL-8810 (46% vs. 
36%; P=0.04; Figures 16). No differences on pregnancy rates by quality or stage or by 
treatment interactions on pregnancy rates were observed (Figures 16 and 17; 
respectively). 
 
5. Discussion 
Currently, MOET programs in beef and dairy cows are utilized worldwide for 
rapid acquisition of superior animals. However, the costs of superovulation treatment, 
labor, and the variability in superovulatory response and pregnancy rates after embryo 
transfer make this technique economically unappealing to the great majority of producers. 
Several factors such as recipient management, age of recipient animal (reviewed by 
(Stroud and Hasler, 2006), synchrony between estrous cycles of donor and recipient cows  
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Figure 13. In vitro blastocyst development of frozen-thawed in vivo-derived embryos 
cultured in KSOM medium with 1000 nM AL-8810 (AL, n= 94), 1000 nM AL-8810 + 10 
ng/mL prostaglandin F2α (AL+PGF, n= 94), 10 ng/mL prostaglandin F2α (PGF, n= 94), 
and Control (CON, n= 91). Standard errors were ± 3.7.  
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Figure 14. Relative abundance of Na+/K+ ATPase mRNA expression of in vivo-derived 
embryos cultured in KSOM medium with 1000 nM AL-8810 (AL), 1000 nM AL-8810 + 
10 ng/mL prostaglandin F2α (AL+PGF), 10 ng/mL prostaglandin F2α (PGF), and Control 
(CON). Standard errors were ± 0.14 for each treatment. 
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Figure 15. Relative abundance of ZO-1 mRNA expression of in vivo-derived embryos 
cultured in KSOM medium with 1000 nM AL-8810 (AL), 1000 nM AL-8810 + 10 
ng/mL prostaglandin F2α (AL+PGF), 10 ng/mL prostaglandin F2α (PGF), and Control 
(CON). Standard errors were ± 0.25 for each treatment.  
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Figure 16. Pregnancy rates following transfer of embryos collected in medium containing 
AL-8810 were increased compared to controls. The interaction of collection medium 
treatment with embryo quality 1 or 2 did not differ. a,b Values differ between treatments; 
P<0.05. Standard errors were ± 0.06 for AL-8810 and Con flush medium, and ± 0.06, 
±0.08, ±0.06, ±0.09 for the interaction of AL-8810 with quality 1, AL-8810 with quality 
2, Con with quality 1, and Con with quality 2.  
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Figure 17. Pregnancy rates following transfer of embryos collected in medium containing 
AL-8810 were increased compared to controls. The interaction of collection medium 
treatment with stage of the embryo (compact morula or blastocyst) did not differ. a,b 
Values differ between treatments; P<0.05. Standard errors were ± 0.06 for AL-8810 and 
Con flush medium, and ± 0.07, ±0.07, ±0.07, ±0.08 for the interaction of AL-8810 with 
compact morula, AL-8810 with blastocyst, Con with compact morula, and Con with 
blastocyst.  
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(Wright, 1981), infectious diseases (Vanroose et al., 2000), toxins (Woclawek-Potocka et 
al., 2005), uterine environment composition (elevated concentrations of urea and PGF2α 
(Schrick et al., 1993; Butler, 1998; Scenna et al., 2005), and several others factors, can 
influence pregnancy rates following embryo transfer to recipient cows. Pregnancy rates 
after non-surgical embryo transfer of in vivo-derived frozen-thawed (ethylene glycol) 
embryos is about 40 to 55% (Leibo, 1986; Malayer et al., 1990; Nibart and Humblot, 
1997; Lester and McNew, 1999), whereas those obtained after transfer of fresh embryos 
are about 55% to 80% (Hasler, 2001). Development of new strategies aimed at increasing 
pregnancy rates after embryo transfer will increase efficiency of this technique and lower 
costs to cattle owners. Therefore, the objective of this study was to reduce reproductive 
losses associated with negative effects of PGF2α on the embryo after performing embryo 
transfer in cattle.  
In the cow, hatching is a critical step for establishment of a successful pregnancy 
because it allows filamentous development of the embryo and posterior attachment of the 
embryo to the uterine endometrium. Similarly, low implantation rates of in vitro-
fertilized human embryos are largely due to impaired development and hatching of 
blastocyst (Magli et al., 1998). In cattle, accumulation of fluid (between days 8 and 10 
after fertilization) within the blastocoel cavity of the blastocyst distends the ZP until it 
ruptures allowing hatching of the blastocyst by protrusion through the opening in the ZP 
(Flechon and Renard, 1978; Massip and Mulnard, 1980). Accumulation of fluid within 
the blastocoel cavity is achieved by a sodium concentration gradient created by the 
presence and activity of Na+/K+-ATPase pump (Biggers et al., 1988) at the basolateral 
surface of the trophectoderm epithelium. Additionally, presence of a junctional apical 
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complex (formed by tight junction and adheren junctions at the apical part of the TE 
epithelium) prevents uncontrolled leakage of this fluid from the blastocoel cavity 
(Watson et al., 1992; Bavister, 1995).  
Manipulation of the reproductive tract has been shown to increase release of 
PGF2α from the uterine endometrium in the cow (Scenna et al., 2005), sow (Kunavongkrit 
et al., 1984), and mare (Kask and Odensvik, 1995). Elevated uterine concentrations of 
PGF2α in the uterine lumen caused by mechanical manipulation of the uterus at the time 
of embryo transfer may create a “hostile environment” for embryonic development. In 
fact, Schrick et al. (1993) observed that quality of bovine embryos tended to be 
negatively correlated with concentrations of PGF2α in the flushing media. Furthermore, 
Scenna et al. (2004) demonstrated that development of in vitro-produced pre-compacted 
embryos to blastocyst stage and hatching rates of in vivo-derived bovine embryos were 
directly reduced by PGF2α. Prostaglandin F2α has also been shown to decrease pregnancy 
rates in cows provided supplemental progesterone (Buford et al., 1996; Seals et al., 1998; 
Lemaster et al., 1999). Further involvement of PGF2α as an embryotoxic agent was 
observed on embryonic development of rat, mouse, and rabbit embryos in vitro (Harper 
and Skarnes, 1972; Maurer and Beier, 1976; Breuel et al., 1993).  
In our initial study, orthogonal contrast indicated a strong tendency for improved 
in vitro development of embryos treated with AL-8810 before exposure to PGF2α (1000 
AL + PGF-10 group) when compared to embryos treated with PGF2α alone (PGF-10 
group). Moreover, evaluation of relative abundance of important genes participating in 
blastocyst formation and successful hatching (Na+/K+ ATPase α1 isoform and ZO-1, a 
protein constituent of tight junctions) of bovine embryos did not differ among treatments. 
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Therefore, negative effects of PGF2α on embryonic development of in vivo-derived 
bovine embryos do not appear to be mediated by a reduction on gene expression of genes 
participating in blastocyst formation nor hatching. However, another explanation for the 
lack of effects of PGF2α on gene expression in those two genes may be related to the 
presence of several other Na+/K+ ATPase isoforms (Betts et al., 1997) and several other 
proteins that contribute to tight junction assembly (Stevenson and Keon, 1998). 
Prostaglandin F2α may also decrease embryonic development by altering the activity of 
the Na+/K+ ATPase pump and increasing permeability of tight junctions through post-
translational modification (especially by activation of PKC) of these proteins. 
It worth noting that the percent difference between 1000 AL + PGF-10 (57%) and 
PGF-10 (46%) on development to blastocyst in vitro was in the order of 11%. Similarly, 
a 10% difference on pregnancy rates after transfer of embryos previously exposed to AL-
8810 (46%) or embryos not exposed to the receptor antagonist (36%) was observed in 
vivo. Since uterine manipulation induces synthesis and release of PGF2α from the uterine 
endometrium to the uterine lumen, in vitro development of embryos in 1000 AL + PGF-
10 and PGF-10 would “mimic” our in vivo conditions when transferring embryos treated 
with (Flush-AL) or without AL-8810 (Flush-Con) into recipient cows. Therefore, our in 
vitro conditions appear to represent an excellent model for the study of PGF2α effects on 
development of bovine embryos as well as for the development of therapeutic strategies 
that can later be applied in vivo.  
The improvement on pregnancy rates observed in our study agreed with previous 
data from our laboratory in which administration of flunixin meglumine to recipient cows 
at the time of embryo transfer increased pregnancy rates (Scenna et al., 2005). In 
 122
addition, Elli et al. (2001), McNaughtan et al. (2002), Pugh et al. (2004) and Purcell et al. 
(2004) also reported beneficial effects of prostaglandin synthesis inhibitors on pregnancy 
rates after embryo transfer in recipient cows. The increase on pregnancy rates in the 
present study after utilization of a selective FPr antagonist (10%) was higher than the 
increase on pregnancy rates observed after administration of flunixin meglumine (5%) 
reported by Scenna et al. (2005). An explanation for differences on pregnancy rates 
between these two studies may be explained by 1) a more efficient means of inhibiting 
PGF2α effects inside the uterus (readily available FPr antagonist in the collection medium 
vs. parenteral administration of flunixin meglumine), and/or 2) by only inhibiting the 
effects of PGF2α on the embryo by AL-8810 vs. the inhibition of all prostaglandins 
synthesis with the administration of flunixin meglumine, a non-specific inhibitor of 
cyclooxygenase synthases-1 and -2 enzymes (Cheng et al., 1998; Campbell and 
Blikslager, 2000). As a consequence, flunixin meglumine inhibits synthesis of all 
prostaglandins, including those considered beneficial for embryo development (especially 
PGE2; (Biggers et al., 1978; Gurevich et al., 1993).  
Our results suggest that inability of PGF2α to interact with its receptors (by the 
utilization of a PGF2α receptor antagonist in the flushing medium) on bovine embryos at 
the time of embryo recovery improves pregnancy rates of those embryos transferred to 
recipient cows. These findings will increase the efficiency of embryo transfer programs 
in cattle and lower the costs associated with this procedure by increasing the number of 
pregnancies after transfer. 
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CHAPTER 6 
SUMMARY 
 
Reproductive losses associated with the beef industry in the United States are 
estimated to cost $500 million dollars annually (Bellows et al., 2002). Previous studies 
have shown detrimental effects of prostaglandin F2α (PGF2α) on in vitro development of 
rat, rabbit and bovine embryos (Maurer and Beier, 1976; Breuel et al., 1993; Scenna et 
al., 2004). Moreover, elevated concentrations of PGF2α decreased embryonic 
development, quality and hatching ability of embryos and pregnancy rate in cows, even 
in the presence of supplemental progesterone (Schrick et al., 1993; Buford et al., 1996; 
Lemaster et al., 1999; Elli et al., 2001; Hockett et al., 2004; Sales et al., 2004). Therefore, 
PGF2α is a major cause of reproductive inefficiency in cows and results in vast economic 
losses for the cattle industry. 
To date, the mechanisms through which PGF2α reduces embryonic survival and 
development in the cow are still unclear. In addition, the presence of prostaglandin PGF2α 
receptors (FPr) in early stage bovine embryos has not been documented in the literature. 
Lack of information regarding presence of FPr in bovine embryos did not allow for direct 
therapeutic strategies aimed at inhibiting PGF2α effects associated with reproductive 
inefficiency in cattle. However, non-selective inhibitors of prostaglandin synthesis have 
been shown to increase pregnancy rates after embryo transfer to recipient animals in 
cattle (Elli et al., 2001; McNaughtan et al., 2002; Pugh et al., 2004; Purcell et al., 2004; 
Scenna et al., 2005).  
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For the first time in the literature, we demonstrated the presence of FPr mRNA 
and protein in pre-attachment bovine embryos. Discovery of FPr in bovine embryos 
allowed us to develop new therapeutic strategies to improve embryo quality, development 
and survival in cows. Our initial experiments determined that the FPr antagonist AL-8810 
had no negative (or toxic) effects on development of in vitro- and in vivo-derived bovine 
embryos. Secondly, we observed that AL-8810 inhibited detrimental effects of PGF2α 
development of in vitro- and in vivo-derived bovine embryos. Finally, we demonstrated 
that addition of AL-8810 to the collection medium during recovery of bovine embryos in 
donor cows was able to increase pregnancy rates following transfer of these embryos to 
recipient cows. Thus, our results indicated that addition of AL-8810 inhibits direct 
negative effects of PGF2α on in vitro (before compaction) and in vivo (after compaction) 
embryo development by preventing PGF2α to interact with its cell surface receptor in 
bovine embryos. 
During embryo transfer, manipulation of the reproductive tract may trigger an 
inflammatory process in the uterus with release of several chemical mediators. One of 
these mediators, TNF-α, has been shown to activate cPLA2 in endometrial cells (Okuda et 
al., 2002). Activation of cPLA2 in endometrial cells will stimulate PGF2α synthesis and 
release into the uterine lumen. In fact, Scenna et al. (2005) reported increased plasma 
concentrations of PGF2α following manipulation of the reproductive tract after embryo 
transfer. Prostaglandin F2α released into the uterine lumen may also stimulate its own 
synthesis and release from endometrial cells (Wade and Lewis, 1996), and thus, 
increasing intralumenal concentrations of PGF2α. Based on our results, we hypothesize 
that PGF2α alters embryonic development by binding to its own receptor and triggering a 
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cascade of events (Figure 18) leading to: 1) inability to compact of pre-compacted 
embryos, and 2) decrease hatching rates of compacted embryos. It can be speculated that 
the effects of PGF2α are not all or none, but enough to cause a temporary decrease on 
embryonic development. These effects will result in reduced embryo development and 
hatching rates. As a consequence, an asynchrony between the uterus and the stage of the 
embryo will result in a retarded embryo not able to secrete interferon-τ at the moment of 
spontaneous luteolysis in the cow and resulting in embryonic loss.  
We hypothesize that binding of PGF2α to its receptor causes downstream signaling 
events (mobilization of intracellular Ca++, activation of PKC and MAPK’s) leading to 
disruption, destruction or synthesis inhibition (by decreasing gene expression) of cell-cell 
adhesion molecules, but especially E-cadherin and tight junctions. In addition, PGF2α–
associated signaling events may cause post-translational regulations of several important 
proteins, such as Na+/K+ ATPase pump, and decrease their physiological activities (Kim 
and Yeoun, 1983). Therefore, effects of PGF2α will result in a decrease on the ability of 
the embryo to either compact (especially by altering E-cadherin assembly or activity) or 
hatch from the zona pellucida (especially by altering tight junctions and Na+/K+ ATPase 
pump assembly or activity) (Figure 18).  
Improving pregnancy rate after embryo transfer in cows using AL-8810 will 
allow for development of new therapeutic techniques in other species, including humans, 
to increase reproduction and success rates. These findings will also allow to increase the 
efficiency of embryo transfer programs in cattle and to lower the costs associated with 
this technique, making it more appealing to cattle owners. Lastly, inhibition of 
detrimental effects of PGF2α on bovine reproduction will result in better reproductive 
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Figure 18. Proposed mechanisms of action of PGF2α on development of bovine embryos. 
Following synthesis and release of PGF2α to the uterine lumen, PGF2α can interact with its 
own receptor (FPr) at the cell membrane of blastomeres and trigger a cascade of signaling 
events (G-protein/Phospholipase C/Ca++/DAG/PKC/MAPK) or diffuse to the cytoplasm 
of the blastomeres without interacting with its receptor. In addition, PGF2α can stimulate 
its own production in the uterine endometrium increasing its concentrations in the uterine 
lumen and also inducing synthesis of matrix metalloproteinases with the ability to 
destruct tight junctions. These signaling events will modify assembly and/or functions of 
E-cadherin, tight junctions or Na+/K+ ATPase proteins affecting compaction and hatching 
of the embryos. 
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efficiency (higher pregnancy rates) and higher monetary earnings to the cattle industry 
(increase on cattle sales). 
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